OriginClear (OCLN) 10-Q 16 May 22 2022 Q1 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	3 Months Ended
	Mar. 31, 2022	May 13, 2022
Document Information Line Items
Entity Registrant Name	ORIGINCLEAR, INC.
Document Type	10-Q
Current Fiscal Year End Date	--12-31
Entity Common Stock, Shares Outstanding		571,161,924
Amendment Flag	false
Entity Central Index Key	0001419793
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Document Period End Date	Mar. 31, 2022
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q1
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Document Quarterly Report	true
Document Transition Report	false
Entity File Number	333-147980
Entity Incorporation, State or Country Code	NV
Entity Tax Identification Number	26-0287664
Entity Address, Address Line One	13575 58th Street North
Entity Address, Address Line Two	Suite 200
Entity Address, City or Town	Clearwater
Entity Address, State or Province	FL
Entity Address, Postal Zip Code	33760
City Area Code	(727)
Local Phone Number	440-4603
Entity Interactive Data Current	Yes

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Mar. 31, 2022	Dec. 31, 2021
CURRENT ASSETS
Cash	$ 793,188	$ 272,470
Restricted cash	1,061,227	433,951
Contracts receivable	1,039,746	2,150,967
Fair value investment in securities, current	94,940	198,918
Contract assets	781,967	378,932
Inventory assets	2,850	2,850
Prepaid expenses	12,363	13,111
TOTAL CURRENT ASSETS	3,786,281	3,451,199
NET PROPERTY AND EQUIPMENT	202,658	213,391
OTHER ASSETS
Long term assets held for sale	514,000	514,000
Fair value investment-securities	8,800	17,600
Trademark	4,467	4,467
TOTAL OTHER ASSETS	527,267	536,067
TOTAL ASSETS	4,516,206	4,200,657
Current Liabilities
Accounts payable and other payable	1,434,056	1,452,229
Accrued expenses	1,531,544	1,533,404
Cumulative preferred stock dividends payable	352,359	356,728
Contract liabilities	2,494,825	1,886,946
Capital lease, current portion	5,713	7,985
Customer deposit	146,453	146,453
Warranty reserve	20,000	20,000
Loan payable, merchant cash advance	30,646	80,646
Loans payable, SBA	150,000	150,000
Derivative liabilities	7,852,842	6,526,129
Total Current Liabilities	16,516,596	16,277,207
Long Term Liabilities
Capital lease, long term portion
Convertible promissory notes, net of discount of $0 and $0, respectively	1,416,147	62,275
Total Long Term Liabilities	1,416,147	62,275
Total Liabilities	17,932,743	16,339,482
COMMITMENTS AND CONTINGENCIES (See Note 11)
SHAREHOLDERS’ DEFICIT
Subscription payable to purchase	100,000	100,000
Preferred treasury stock, 1,000 and 1,000 shares outstanding, respectively Common stock, $0.0001 par value, 16,000,000,000 shares authorized 526,305,492 and 306,883,932 equity shares issued and outstanding, respectively	52,630	30,688
Additional paid in capital - Common stock	77,455,906	75,720,147
Accumulated other comprehensive loss	(132)	(132)
Accumulated deficit	(101,752,190)	(98,175,924)
TOTAL SHAREHOLDERS’ DEFICIT	(24,140,482)	(22,321,917)
TOTAL LIABILITIES AND SHAREHOLDERS’ DEFICIT	4,516,206	4,200,657
Series F 8% Preferred Stock
Current Liabilities
Preferred stock value	160,000	160,000
Series F 8% Convertible Preferred Stock One
Current Liabilities
Preferred stock value		100,000
Series G 8% Preferred Stock
Current Liabilities
Preferred stock value	25,000	25,000
Series I 8% Preferred Stock
Current Liabilities
Preferred stock value	235,000	235,000
Series K 8% Preferred Stock
Current Liabilities
Preferred stock value	482,150	580,650
Convertible promissory notes, net of discount of $0 and $3,743, respectively	1,596,008	3,016,037
Series J Convertible Preferred Stock
Long Term Liabilities
Convertible preferred stock	215,000	215,000
Series L Convertible Preferred Stock
Long Term Liabilities
Convertible preferred stock	486,245	609,825
Series M Preferred Stock
Long Term Liabilities
Convertible preferred stock	1,007,500	1,007,500
Series O 8% Convertible Preferred Stock
Long Term Liabilities
Convertible preferred stock	615,000	615,000
Series P Convertible Preferred Stock
Long Term Liabilities
Convertible preferred stock	57,500	57,500
Series Q 12% Convertible Preferred Stock
Long Term Liabilities
Convertible preferred stock	615,000	515,000
Series R 10% Convertible Preferred Stock
Long Term Liabilities
Convertible preferred stock	3,054,000	3,432,267
Series S 12% Convertible Preferred Stock
Long Term Liabilities
Convertible preferred stock	170,000	170,000
Series T 10% Convertible Preferred Stock
Long Term Liabilities
Convertible preferred stock	485,000	630,000
Series U Convertible Preferred Stock
Long Term Liabilities
Convertible preferred stock	635,000	1,066,500
Series V Convertible Preferred Stock
Long Term Liabilities
Convertible preferred stock		400,000
Series W 12% Convertible Preferred Stock
Long Term Liabilities
Convertible preferred stock	769,500	744,500
Series X Convertible Preferred Stock
Long Term Liabilities
Convertible preferred stock	250,000	250,000
Series Y Convertible Preferred Stock
Long Term Liabilities
Convertible preferred stock	2,114,200	470,000
Series Z Convertible Preferred Stock
Long Term Liabilities
Convertible preferred stock	250,000
Convertible preferred stock, total	10,723,945	10,183,092
Series C Preferred Stock
Current Liabilities
Preferred stock value
Series D-1 Preferred Stock
Current Liabilities
Preferred stock value	3,150	3,150
Series E Preferred Stock
Current Liabilities
Preferred stock value	$ 154	$ 154

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parentheticals) - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Preferred stock, shares outstanding	635
Long term net of discount current (in Dollars)	$ 0	$ 0
Common stock, shares issued	526,305,492	306,883,932
Common stock, shares outstanding	526,305,492	306,883,932
Preferred treasury stock, shares outstanding	1,000	1,000
Common stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized	16,000,000,000	16,000,000,000
Series F 8% Preferred Stock
Preferred stock, shares issued	160	160
Preferred stock, shares outstanding	160	160
Preferred stock, redeemable value (in Dollars)	$ 160,000	$ 175,000
Series F 8% Convertible Preferred Stock One
Preferred stock, shares issued	0	100
Preferred stock, shares outstanding	0	100
Preferred stock, redeemable value (in Dollars)	$ 0	$ 100,000
Series G 8% Preferred Stock
Preferred stock, shares issued	25	25
Preferred stock, shares outstanding	25	25
Preferred stock, redeemable value (in Dollars)	$ 25,000	$ 25,000
Series I 8% Preferred Stock
Preferred stock, shares issued	235	235
Preferred stock, shares outstanding	235	235
Preferred stock, redeemable value (in Dollars)	$ 235,000	$ 235,000
Series K 8% Preferred Stock
Preferred stock, shares issued	482	581
Preferred stock, shares outstanding	482	581
Preferred stock, redeemable value (in Dollars)	$ 482,150	$ 580,650
Net of discount current (in Dollars)	0	3,743
Series J Convertible Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 215,000	$ 215,000
Convertible preferred stock, shares issued	215	215
Convertible preferred stock, shares outstanding	215	215
Series L Convertible Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 486,245	$ 609,825
Convertible preferred stock, shares issued	486	610
Convertible preferred stock, shares outstanding	486	610
Series M Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 1,007,500	$ 1,007,500
Convertible preferred stock, shares issued	40,300	40,300
Convertible preferred stock, shares outstanding	40,300	40,300
Series O 8% Convertible Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 615,000	$ 615,000
Convertible preferred stock, shares issued	615	615
Convertible preferred stock, shares outstanding	615	615
Series P Convertible Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 57,500	$ 57,500
Convertible preferred stock, shares issued	57.5	57.5
Convertible preferred stock, shares outstanding	57.5	57.5
Series Q 12% Convertible Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 615,000	$ 515,000
Convertible preferred stock, shares issued	615	515
Convertible preferred stock, shares outstanding	615	515
Series R 10% Convertible Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 3,054,000	$ 3,432,267
Convertible preferred stock, shares issued	3,054	3,432
Convertible preferred stock, shares outstanding	3,054	3,432
Series S 12% Convertible Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 170,000	$ 170,000
Convertible preferred stock, shares issued	170	170
Convertible preferred stock, shares outstanding	170	170
Series T 10% Convertible Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 485,000	$ 630,000
Convertible preferred stock, shares issued	485	630
Convertible preferred stock, shares outstanding	485	630
Series U Convertible Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 635,000	$ 1,066,500
Convertible preferred stock, shares issued	635	1,066.5
Convertible preferred stock, shares outstanding	635	1,066.5
Series V Convertible Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 0	$ 400,000
Convertible preferred stock, shares issued	0	4
Convertible preferred stock, shares outstanding	0	4
Series W 12% Convertible Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 769,500	$ 744,500
Convertible preferred stock, shares issued	769.5	744.5
Convertible preferred stock, shares outstanding	769.5	744.5
Series X Convertible Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 250,000	$ 250,000
Convertible preferred stock, shares issued	250	250
Convertible preferred stock, shares outstanding	250	250
Series Y Convertible Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 2,114,200	$ 470,000
Convertible preferred stock, shares issued	21.1	4.7
Convertible preferred stock, shares outstanding	21.1	4.7
Series Z Convertible Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 250,000	$ 0
Convertible preferred stock, shares issued	25	0
Convertible preferred stock, shares outstanding	25	0
Series C Preferred Stock
Preferred stock, shares issued	1,000	1,000
Preferred stock, shares outstanding	1,000	1,000
Preferred stock par value (in Dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	550,000,000	550,000,000
Series D-1 Preferred Stock
Preferred stock, shares issued	31,500,000	31,500,000
Preferred stock, shares outstanding	31,500,000	31,500,000
Series E Preferred Stock
Preferred stock, shares issued	1,537,213	1,537,213
Preferred stock, shares outstanding	1,537,213	1,537,213

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Income Statement [Abstract]
Sales	$ 1,234,105	$ 796,178
Cost of Goods Sold	1,458,855	691,521
Gross Profit	(224,750)	104,657
Operating Expenses
Selling and marketing expenses	646,184	431,508
General and administrative expenses	880,260	818,553
Depreciation and amortization expense	10,733	11,631
Total Operating Expenses	1,537,177	1,261,692
Loss from Operations	(1,761,927)	(1,157,035)
OTHER INCOME (EXPENSE)
Other income		1
Gain on write of loans payable	75,000
Loss on conversion of preferred stock	(210,997)	(790,812)
Loss on exchange of preferred stock		(40,000)
Unrealized gain (loss) on investment securities	(112,778)	45,200
Loss on net change in derivative liability and conversion of debt	(1,326,713)	(15,651,708)
Interest expense	(238,852)	(263,221)
TOTAL OTHER (EXPENSE) INCOME	(1,814,340)	(16,700,540)
NET INCOME (LOSS)	(3,576,267)	(17,857,575)
WARRANTS DEEMED DIVIDENDS		(2,037,849)
NET (LOSS) ATTRIBUTABLE TO SHAREHOLDERS INCOME	$ (3,576,267)	$ (19,895,424)
BASIC EARNINGS (LOSS) PER SHARE ATTRIBUTABLE TO SHAREHOLDERS’ (in Dollars per share)	$ (0.01)	$ (0.19)
DILUTED EARNINGS (LOSS) PER SHARE ATTRIBUTABLE TO SHAREHOLDERS’ (in Dollars per share)	$ (0.01)	$ (0.19)
WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING,
BASIC (in Shares)	416,397,236	91,595,414
DILUTED (in Shares)	416,397,236	91,595,414

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Shareholders’ Deficit - USD ($)	Preferred stock	Mezzanine Equity	Common stock	Additional Paid-in- Capital	Subscription Payable	Accumulated Other Comprehensive loss	Accumulated Deficit	Total
Balance at Dec. 31, 2020	$ 3,404	$ 6,331,409	$ 6,505	$ 64,265,217	$ 100,000	$ (132)	$ (94,020,294)	$ (29,645,300)
Balance (in Shares) at Dec. 31, 2020	34,038,213		65,052,688
Rounding
Common stock issuance for conversion of debt and accrued interest			$ 635	60,371				61,006
Common stock issuance for conversion of debt and accrued interest (in Shares)			6,354,895
Common stock issued at fair value for services			$ 477	338,642				339,119
Common stock issued at fair value for services (in Shares)			4,766,280
Common stock issued for conversion of Series J Preferred stock		(32,500)	$ 98	32,402				32,500
Common stock issued for conversion of Series J Preferred stock (in Shares)			978,726
Common stock issued for conversion of Series L Preferred stock		(301,259)	$ 999	300,260				301,259
Common stock issued for conversion of Series L Preferred stock (in Shares)			9,988,447
Common stock issued for Series O Preferred stock dividends			$ 24	(24)
Common stock issued for Series O Preferred stock dividends (in Shares)			236,205
Common stock issued for conversion of Series O Preferred stock		(469,500)	$ 1,284	468,216				469,500
Common stock issued for conversion of Series O Preferred stock (in Shares)			12,844,190
Common stock issued for conversion of Series P Preferred stock		(126,000)	$ 658	125,342				126,000
Common stock issued for conversion of Series P Preferred stock (in Shares)			6,583,405
Common stock issued for conversion of Series Q Preferred stock		(74,000)	$ 205	73,795				74,000
Common stock issued for conversion of Series Q Preferred stock (in Shares)			2,052,526
Common stock issued for conversion of Series R Preferred stock		(98,500)	$ 289	98,211				98,500
Common stock issued for conversion of Series R Preferred stock (in Shares)			2,891,618
Common stock issued for conversion of Series S Preferred stock		(45,000)	$ 115	44,885				45,000
Common stock issued for conversion of Series S Preferred stock (in Shares)			1,149,050
Issuance of Series M Preferred stock through a private placement		29,425
Issuance of Series R Preferred stock through a private placement		1,080,000
Issuance of Series T Preferred stock in exchange for property		630,000
Exchange of Series G Preferred stock for Series S Preferred stock		210,000
Exchange of Series I Preferred stock for Series R Preferred stock		72,400
Exchange of Series K Preferred stock for Series R Preferred stock		483,767
Exchange of Series M Preferred stock for Series R Preferred stock		40,000
Loss on conversion of Preferred stock				790,812				790,812
Issuance of Common stock warrants deemed dividends				2,037,849				2,037,849
Net Income (loss)							(19,895,424)	(19,895,424)
Balance at Mar. 31, 2021	$ 3,404	7,730,242	$ 11,289	68,635,978	100,000	(132)	(113,915,718)	(45,165,179)
Balance (in Shares) at Mar. 31, 2021	34,038,213		112,898,030
Balance at Dec. 31, 2021	$ 3,304	10,183,092	$ 30,688	75,720,147	100,000	(132)	(98,175,924)	(22,321,917)
Balance (in Shares) at Dec. 31, 2021	33,038,213		306,883,932
Rounding			$ 2	(3)			1
Common stock issuance for conversion of debt and accrued interest			$ 1,246	118,388				119,634
Common stock issuance for conversion of debt and accrued interest (in Shares)			12,461,909
Common stock issued at fair value for services			$ 1,331	337,393				338,724
Common stock issued at fair value for services (in Shares)			13,314,289
Common stock issued for conversion of Series L Preferred stock		(123,580)	$ 1,453	122,127				123,580
Common stock issued for conversion of Series L Preferred stock (in Shares)			14,528,106
Common stock issued for Series O Preferred stock dividends			$ 26	(26)
Common stock issued for Series O Preferred stock dividends (in Shares)			261,707
Common stock issued for conversion of Series R Preferred stock		(378,267)	$ 2,612	375,655				378,267
Common stock issued for conversion of Series R Preferred stock (in Shares)			26,120,791
Common stock issued for conversion of Series T Preferred stock		(145,000)	$ 1,719	143,281				145,000
Common stock issued for conversion of Series T Preferred stock (in Shares)			17,193,676
Common stock issued for conversion of Series U Preferred stock		(431,500)	$ 2,279	429,221				431,500
Common stock issued for conversion of Series U Preferred stock (in Shares)			22,794,493
Common stock issued for conversion of Series W Preferred stock		(10,000)	$ 69	9,931				10,000
Common stock issued for conversion of Series W Preferred stock (in Shares)			694,446
Common stock issued for make good shares for Series R Preferred stock			$ 104	(104)
Common stock issued for make good shares for Series R Preferred stock (in Shares)			1,041,662
Common stock issued for conversion settlement			$ 11,101	(11,101)
Common stock issued for conversion settlement (in Shares)			111,010,481
Issuance of Series Y Preferred stock through a private placement		1,244,200
Issuance of Series Z Preferred stock through a private placement		250,000
Exchange of Series F Preferred stock for Series Q Preferred stock		100,000
Exchange of Series K Preferred stock for Series W Preferred stock		35,000
Exchange of Series V Preferred stock for Series Y Preferred stock
Loss on conversion of Preferred stock				210,997				210,997
Net Income (loss)							(3,576,267)	(3,576,267)
Balance at Mar. 31, 2022	$ 3,304	$ 10,723,945	$ 52,630	$ 77,455,906	$ 100,000	$ (132)	$ (101,752,190)	$ (24,140,482)
Balance (in Shares) at Mar. 31, 2022	33,038,213		526,305,492

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Income (Loss)	$ (3,576,267)	$ (17,857,575)
Depreciation and amortization	10,733	11,631
Common and preferred stock issued for services	338,724	339,120
(Gain) Loss on net change in valuation of derivative liability	1,326,713	15,651,708
Debt discount recognized as interest expense	3,743	14,729
Net unrealized (gain) loss on fair value of securities	112,778	(45,200)
Loss on exchange of preferred stock		40,000
(Gain) Loss on conversion of preferred stock	210,997	790,812
Gain on write off of payable	(50,000)
Contracts receivable	1,111,221	(67,028)
Contract asset	(403,035)	78,301
Inventory asset		(1,900)
Prepaid expenses and other assets	748	39,505
Other receivable		(1,315)
Accounts payable	(13,672)	5,723
Accrued expenses	47,873	17,896
Contract liabilities	607,879	(16,072)
NET CASH USED IN OPERATING ACTIVITIES	(271,565)	(999,665)
CASH FLOWS USED FROM INVESTING ACTIVITIES:
Purchase of fixed assets	(4,500)	(4,500)
NET CASH USED IN INVESTING ACTIVITIES	(4,500)	(4,500)
CASH FLOWS FROM FINANCING ACTIVITIES:
Payments on capital lease	(2,272)	(2,272)
Repayment of loans, related party, net		(23,747)
Net payments on cumulative preferred stock dividends payable	(4,369)	17,595
Proceeds on convertible promissory notes		60,000
Payments on promissory notes		(14,800)
Net proceeds for issuance of preferred stock for cash - mezzanine classification	1,430,700	1,109,425
NET CASH PROVIDED BY FINANCING ACTIVITIES	1,424,059	1,146,201
NET INCREASE IN CASH	1,147,994	142,036
CASH BEGINNING OF PERIOD	706,421	416,121
CASH END OF PERIOD	1,854,415	558,157
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Interest and dividends paid	180,898	2,281
Taxes paid
SUPPLEMENTAL DISCLOSURES OF NON CASH TRANSACTIONS
Common stock issued at fair value for conversion of debt, plus accrued interest, and other fees	119,634	61,007
Common stock issued for settlements	11,101
Issuance of Series T preferred stock in exchange for property		630,000
Issuance of Series O dividends	26	24
Preferred stock converted to common stock		1,146,759
Conversion of debt to mezzanine preferred stock	135,000
Conversion of mezzanine preferred stock to common	1,088,347
Exchange from mezzanine to liability		766,167
Issuance of warrants deemed dividends		2,037,849
Fair value of derivative at issuance		$ 54,652

Basis of Presentation

Basis of Presentation	3 Months Ended
	Mar. 31, 2022
Accounting Policies [Abstract]
Basis of Presentation	1. Basis of Presentation The accompanying unaudited condensed consolidated financial statements of OriginClear, Inc. (the “Company”) have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all normal recurring adjustments considered necessary for a fair presentation have been included. Operating results for the three months ended March 31, 2022 are not necessarily indicative of the results that may be expected for the year ending December 31, 2022. For further information refer to the financial statements and footnotes thereto included in the Company’s Form 10-K for the year ended December 31, 2021. The Company has implemented a new outsourced water treatment business called Water On Demand (“WOD”). The WOD model intends to offer private businesses water self-sustainability as a service. Four subsidiaries have been established to house capital dedicated to this program. During the three months ended March 31, 2022, the Water On Demand business reached its first $1 million milestone in dedicated capital. The Company is evaluating the first pilot opportunity to enable a commercial customer to treat its dirty water by the gallon as a managed service, instead of the client having to come up with significant up-front capital. The Company has announced that it plans to spin off the WOD business into its newly formed wholly owned subsidiary, Water On Demand, Inc. Going Concern The accompanying financial statements have been prepared on a going concern basis of accounting, which contemplates continuity of operations, realization of assets and liabilities and commitments in the normal course of business. The accompanying financial statements do not reflect any adjustments that might result if the Company is unable to continue as a going concern. These factors, among others raise substantial doubt about the Company’s ability to continue as a going concern. Our independent auditors, in their report on our audited financial statements for the year ended December 31, 2021 expressed substantial doubt about our ability to continue as a going concern. The ability of the Company to continue as a going concern and appropriateness of using the going concern basis is dependent upon, among other things, achieving a level of profitable operations and receiving additional cash infusions. During the three months ended March 31, 2022, the Company obtained funds from the sales of its preferred stock. Management believes this funding will continue from its’ current investors and from new investors. For the three months ended March 31, 2022, the Company generated revenue of $1,234,105 and has standing purchase orders and open invoices with customers, which will provide funds for operations. Management believes the existing shareholders, the prospective new investors and future sales will provide the additional cash needed to meet the Company’s obligations as they become due and will allow the development of its core business operations. No assurance can be given that any future financing will be available or, if available, that it will be on terms that are satisfactory to the Company. Even if the Company is able to obtain additional financing, it may contain restrictions on our operations, in the case of debt financing or cause substantial dilution for our stockholders, in case of equity financing.

Summary of Significant Accounti

Summary of Significant Accounting Polices	3 Months Ended
	Mar. 31, 2022
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICES	2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICES This summary of significant accounting policies of the Company is presented to assist in understanding the Company’s financial statements. The financial statements and notes are representations of the Company’s management, which is responsible for their integrity and objectivity. These accounting policies conform to accounting principles generally accepted in the United States of America and have been consistently applied in the preparation of the financial statements. Principles of Consolidation The accompanying consolidated financial statements include the accounts of OriginClear, Inc. and its wholly owned operating subsidiaries, Progressive Water Treatment, Inc., and OriginClear Technologies, Ltd. All material intercompany transactions have been eliminated upon consolidation of these entities. Cash and Cash Equivalent The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include estimates used to review the Company’s impairments and estimations of long-lived assets, revenue recognition on percentage of completion type contracts, allowances for uncollectible accounts, warranty reserves, inventory valuation, derivative liabilities and other conversion features, fair value investments, valuations of non-cash capital stock issuances and the valuation allowance on deferred tax assets. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable in the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. Net Earnings (Loss) per Share Calculations Basic loss per share calculation is computed by dividing income (loss) available to common shareholders by the weighted-average number of common shares available. Diluted earnings per share is computed similarly to basic earnings per share except that the denominator is increased to include securities or other contracts to issue common stock that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. The Company’s diluted earnings per share were not the same as the basic loss per share for the three months ended March 31, 2022 and 2021, respectively, as the inclusion of any potential shares in the three months ended March 31, 2022 and 2021, would have had an anti-dilutive effect due to the Company generating a loss. For the Three Months 2022 2021 Income (Loss) to common shareholders (Numerator) $ (3,576,267 ) $ (19,895,424 ) Basic weighted average number of common shares outstanding (Denominator) 416,397,236 91,595,414 Diluted weighted average number of common shares outstanding (Denominator) 416,397,236 91,595,414 The Company excludes issuable shares from warrants, convertible notes and preferred stock, if their impact on the loss per share is anti-dilutive and includes the issuable shares if their impact is dilutive. Revenue Recognition We recognize revenue when services are performed, and at the time of shipment of products, provided that evidence of an arrangement exists, title and risk of loss have passed to the customer, fees are fixed or determinable, and collection of the related receivable is reasonably assured. Revenues and related costs on construction contracts are recognized as the performance obligations for work are satisfied over time in accordance with Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers. Under ASC 606, revenue and associated profit, will be recognized as the customer obtains control of the goods and services promised in the contract (i.e., performance obligations). All un-allocable indirect costs and corporate general and administrative costs are charged to the periods as incurred. However, in the event a loss on a contract is foreseen, the Company will recognize the loss as it is determined. Revisions in cost and profit estimates during the course of the contract are reflected in the accounting period in which the facts for the revisions become known. Provisions for estimated losses on uncompleted contracts are made in the period in which such losses are determined. Changes in job performance, job conditions, and estimated profitability, including those arising from contract penalty provisions, and final contract settlements, may result in revisions to costs and income, which are recognized in the period the revisions are determined. Contract receivables are recorded on contracts for amounts currently due based upon progress billings, as well as retention, which are collectible upon completion of the contracts. Accounts payable to material suppliers and subcontractors are recorded for amounts currently due based upon work completed or materials received, as are retention due subcontractors, which are payable upon completion of the contract. General and administrative expenses are charged to operations as incurred and are not allocated to contract costs. Contract Receivable The Company bills its customers in accordance with contractual agreements. The agreements generally require billing to be on a progressive basis as work is completed. Credit is extended based on evaluation of clients’ financial condition and collateral is not required. The Company maintains an allowance for doubtful accounts for estimated losses that may arise if any customer is unable to make required payments. Management performs a quantitative and qualitative review of the receivables past due from customers on a monthly basis. The Company records an allowance against uncollectible items for each customer after all reasonable means of collection have been exhausted, and the potential for recovery is considered remote. The allowance for doubtful accounts was $0 and $0 as of March 31, 2022 and December 31, 2021, respectively. The net contract receivable balance was $1,039,746 and $2,150,967 at March 31, 2022 and December 31, 2021, respectively. Indefinite Lived Intangibles and Goodwill Assets The Company accounts for business combinations under the acquisition method of accounting in accordance with ASC 805, “Business Combinations,” where the total purchase price is allocated to the tangible and identified intangible assets acquired and liabilities assumed based on their estimated fair values. The purchase price is allocated using the information currently available, and may be adjusted, up to one year from acquisition date, after obtaining more information regarding, among other things, asset valuations, liabilities assumed and revisions to preliminary estimates. The purchase price in excess of the fair value of the tangible and identified intangible assets acquired less liabilities assumed is recognized as goodwill. The Company tests for indefinite lived intangibles and goodwill impairment in the fourth quarter of each year and whenever events or circumstances indicate that the carrying amount of the asset exceeds its fair value and may not be recoverable. In accordance with its policies, the Company performed a qualitative assessment of indefinite lived intangibles and goodwill at March 31, 2022 and determined there was no impairment of indefinite lived intangibles and goodwill. Property and Equipment Property and equipment are stated at cost. Gain or loss is recognized upon disposal of property and equipment, and the asset and related accumulated depreciation are removed from the accounts. Expenditures for maintenance and repairs are charged to expense as incurred, while expenditures for addition and betterment are capitalized. Furniture and equipment are depreciated on the straight-line method and include the following categories: Estimated Life Machinery and equipment 5-10 years Furniture, fixtures and computer equipment 5-7 years Vehicles 3-5 years Leasehold improvements 2-5 years 3/31/2022 12/31/21 Machinery and Equipment $ 383,569 $ 383,569 Computer Equipment 62,854 62,854 Furniture 29,810 29,810 Leasehold Improvements 26,725 26,725 Vehicles 64,276 64,276 Demo Units 36,139 36,139 603,373 603,373 Less accumulated depreciation (400,715 ) (389,982 ) Net Property and Equipment $ 202,658 $ 213,391 Long-lived assets held and used by the Company are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. In the event that the facts and circumstances indicate that the cost of any long-lived assets may be impaired, an evaluation of recoverability would be performed following generally accepted accounting principles. Depreciation expense during the three months ended March 31, 2022 and March 31, 2021, was $10,733 and $11,631, respectively. Inventory The Company expenses inventory on a first in, first out basis, and had raw materials of $2,850 and $2,850 as of March 31, 2022 and December 31, 2021, respectively. Stock-Based Compensation The Company periodically issues stock options and warrants to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for stock option and warrant grants issued and vesting to employees based on the authoritative guidance provided by the Financial Accounting Standards Board whereas the value of the award is measured on the date of grant and recognized over the vesting period. The Company accounts for stock option and warrant grants issued and vesting to non-employees in accordance with the authoritative guidance of the Financial Accounting Standards Board whereas the value of the stock compensation is based upon the measurement date as determined at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. Non-employee stock-based compensation charges generally are amortized over the vesting period on a straight-line basis. In certain circumstances where there are no future performance requirements by the non-employee, option grants vest immediately and the total stock-based compensation charge is recorded in the period of the measurement date. Accounting for Derivatives The Company evaluates all its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. For stock-based derivative financial instruments, the Company uses a probability weighted average series Binomial lattice option pricing models to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not the net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date. Fair Value of Financial Instruments Fair Value of Financial Instruments requires disclosure of the fair value information, whether or not to recognized in the balance sheet, where it is practicable to estimate that value. As of March 31, 2022, the balances reported for cash, contract receivables, cost in excess of billing, prepaid expenses, accounts payable, billing in excess of cost, and accrued expenses approximate the fair value because of their short maturities. We adopted ASC Topic 820 for financial instruments measured as fair value on a recurring basis. ASC Topic 820 defines fair value, established a framework for measuring fair value in accordance with accounting principles generally accepted in the United States and expands disclosures about fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 established a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include: ● Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets; ● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and ● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. The following table presents certain investments and liabilities of the Company’s financial assets measured and recorded at fair value on the Company’s balance sheets on a recurring basis and their level within the fair value hierarchy as of March 31, 2022. Total (Level 1) (Level 2) (Level 3) Investment at fair value-securities $ 94,940 $ 94,940 $ - $ - Total Assets measured at fair value $ 94,940 $ 94,940 $ - $ - Total (Level 1) (Level 2) (Level 3) Derivative Liability, March 31, 2022 $ 7,852,842 $ - $ - $ 7,852,842 Total liabilities measured at fair value $ 7,852,842 $ - $ - $ 7,852,842 The following is a reconciliation of the derivative liability for which level 3 inputs were used in determining the approximate fair value: Balance as of January 1, 2022 $ 6,526,129 Fair value at issuance - Loss on conversion of debt and change in derivative liability 1,326,713 Balance as of March 31, 2022 $ 7,852,842 For purpose of determining the fair market value of the derivative liability, the Company used Binomial lattice formula valuation model. The significant assumptions used in the Binomial lattice formula valuation of the derivative are as follows: 3/31/22 Risk free interest rate 0.17% - 2.45 % Stock volatility factor 20.0% - 190.0 % Weighted average expected option life 6 months - 5 years Expected dividend yield None Segment Reporting The Company’s business currently operates in one segment based upon the Company’s organizational structure and the way in which the operations are managed and evaluated. Marketable Securities The Company adopted ASU 2016-01, “Financial Instruments – Recognition and Measurement of Financial Assets and Financial Liabilities.” ASU 2016-01 requires investments (except those accounted for under the equity method of accounting, or those that result in consolidation of the investee) to be measured at fair value with changes in fair value recognized in net income. It requires public business entities to use the exit price notion when measuring the fair value of financial instruments for disclosure purpose, and separate presentation of financial assets and financial liabilities by measurement category and form of financial asset. It eliminates the requirement for public business entities to disclose the method(s) and significant assumptions used to estimate the fair value that is required to be disclosed for financial instruments measured at amortized cost. The Company has evaluated the potential impact this standard may have on the condensed consolidated financial statements and determined that it had a significant impact on the condensed consolidated financial statements. The Company accounts for its investment in Water Technologies International, Inc. as available-for-sale securities, and the unrealized gain on the available-for-sale securities is recognized in net income. Licensing agreement The Company analyzed the licensing agreement using ASU 606 to determine the timing of revenue recognition. The licensing of the intellectual property (IP) is distinct from the non-license goods or services and has significant standalone functionality that provides a benefit or value. The functionality will not change during the license period due to the licensor’s activities. Because the significant standalone functionality is delivered immediately, the revenue is generally recognized when the license is delivered. Work-in-Process The Company recognizes as an asset the accumulated costs for work-in-process on projects expected to be delivered to customers. Work in Process includes the cost price of materials and labor related to the construction of equipment to be sold to customers. Recently Issued Accounting Pronouncements Management reviewed currently issued pronouncements and does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the accompanying condensed financial statements.

Capital Stock

Capital Stock	3 Months Ended
	Mar. 31, 2022
Stockholders' Equity Note [Abstract]
CAPITAL STOCK	3. CAPITAL STOCK Preferred Stock Series C On March 14, 2017, the Board of Directors authorized the issuance of 1,000 shares of Series C preferred stock, par value $0.0001 per share, to T. Riggs Eckelberry in exchange for his continued employment with the Company. The holder of Series C preferred stock is not entitled to receive dividends, is not entitled to any liquidation preference and shares of Series C preferred stock does not have any conversion rights. The Series C Preferred Stock entitles the holder to 51% of the total voting power of our stockholders. The purchase price of the Series C preferred stock was $0.0001 per share representing a total purchase price of $0.10 for 1,000 shares. As of March 31, 2022, there were 1,000 shares of Series C preferred stock outstanding held by Mr. Eckelberry. Series D-1 On April 13, 2018, the Company designated 50,000,000 shares of its authorized preferred stock as Series D-1 preferred stock. The shares of Series D-1 preferred stock are not entitled to dividends and do not have a liquidation preference. Each share of Series D-1 preferred stock is convertible into 0.0005 of one share of common stock. The Series D-1 preferred stock may not be converted to common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of our outstanding common stock, which amount may be increased to 9.99% at the holders discretion upon 61 days’ written notice. As of March 31, 2022, there were 31,500,000 shares of Series D-1 preferred stock issued and outstanding. Series E On August 14, 2018, the Company designated 4,000,000 shares of its authorized preferred stock as Series E preferred stock. The shares of Series E preferred stock are not entitled to dividends and not have a liquidation preference. Each share of Series E preferred stock is convertible into 0.05 shares of common stock. The shares of Series E preferred stock do not carry any voting rights. The Series E preferred stock may not be converted to common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of our outstanding common stock which amount may be increased to 9.99% at the holder’s discretion. As of March 31, 2022, there were 1,537,213 shares of Series E preferred stock issued and outstanding. Series F On August 14, 2018, the Company designated 6,000 shares as Series F preferred stock. The shares of Series F preferred stock have a liquidation preference equal to the stated value of $1,000 per share plus any accrued but unpaid dividends. The Series F preferred stock is not convertible into common stock. The holders of outstanding shares of Series F preferred stock are entitled to quarterly dividends at the annual rate of 8% of the stated value, in preference to any dividends on the common stock. The shares of Series F preferred stock do not carry any voting rights. The Company may, in its sole discretion, at any time while the Series F preferred stock is outstanding, redeem all or any portion of the outstanding Series preferred stock at a price equal to the stated value, plus any accrued but unpaid dividends. The Company was required to redeem all outstanding shares of Series F preferred stock on September 1, 2020. As of December 31, 2021, there were 260 shares of Series F preferred stock issued and outstanding. As of December 31, 2021, a holder of 100 of such outstanding shares of Series F preferred stock, agreed that the Company would have no obligation to redeem such holder’s shares of Series F preferred stock prior to September 1, 2022. On February 14, 2022, the Company exchanged those 100 shares of the holder’s Series F preferred stock for 100 shares of Series Q preferred stock. As of March 31, 2022, the Company had 160 outstanding shares of Series F preferred stock, which the Company was required to, and failed to redeem on September 1, 2020, and was and remains in default for an aggregate redemption price (equal to the stated value) of $160,000. Series G On January 16, 2019, the Company designated 6,000 shares as Series G preferred stock, each share having a stated value of $1,000 per share and holders of Series G preferred stock are entitled to cumulative dividends at the annual rate of 8% of the stated value, payable quarterly. The Series G preferred stock does not have voting rights, except as required by law and is not convertible into common stock. The Company may, in its sole discretion, at any time while the Series G preferred stock is outstanding, redeem all or any portion of the outstanding Series G preferred stock at a price equal to the stated value plus any accrued but unpaid dividends. The Company was required to redeem such shares of Series G preferred stock on April 30, 2021, at a price equal to the stated value plus any accrued but unpaid dividends. Pursuant to certain subscription agreements entered into with purchasers of the Series G preferred stock, each purchaser received shares of the Company’s common stock equal to an amount of, for each share of Series G preferred stock purchased, five hundred dollars ($500) divided by the closing price on the date the Company receives the executed subscription documents and purchase price from such investor. As of March 31, 2022, there were 25 shares of Series G preferred stock issued and outstanding, which the Company was required to, and failed to redeem on April 30, 2021, and was and remains in default for an aggregate redemption price (equal to the stated value) of $25,000. Series I On April 3, 2019, the Company designated 4,000 shares of preferred stock as Series I. The Series I has a stated value of $1,000 per share. Series I holders are entitled to cumulative dividends at the annual rate of 8% of the stated value, payable quarterly within 60 days from the end of each fiscal quarter. The Series I is not entitled to any voting rights except as may be required by applicable law, and are not convertible into common stock. The Company has the right to redeem the Series I at any time while the Series I are outstanding at a price equal to the stated value plus any accrued but unpaid dividends. The Company is required to redeem the Series I two years following the date that is the later of the (i) final closing of the tranche (as designated in the applicable subscription agreement) or (ii) the expiration date of the tranche that such shares to be redeemed were a part of. The Company was required to redeem such shares of Series I between May 2, 2021 and June 10, 2021, at a price equal to the stated value plus any accrued but unpaid dividends. The issuances of the shares were accounted for under ASC 480-10-25-4, which requires liability treatment for certain mandatorily redeemable financial instruments, and the cumulative dividends are recorded as interest expense. As of March 31, 2022, there were 235 shares of Series I preferred stock issued and outstanding which the Company was required to, and failed to redeem between May 2, 2021, and June 10, 2021, and was and remains in default for an aggregate redemption price (equal to the stated value) of $235,000. Series J On April 3, 2019, the Company designated 100,000 shares of preferred stock as Series J. The Series J has a stated value of $1,000 per share and holders are entitled to receive dividends on an as-converted basis with the Company’s common stock. The Series J preferred stock is convertible into shares of the Company’s common stock, on the terms and conditions set forth in the Series J COD, which includes certain make-good shares for certain prior investors. As of March 31, 2022, there were 215 shares of Series J preferred stock issued and outstanding. Series K On June 3, 2019, the Company designated 4,000 shares of preferred stock as Series K. The Series K has a stated value of $1,000 per share. Series K holders are entitled to cumulative dividends at the annual rate of 8% of the stated value, payable quarterly within 60 days from the end of each fiscal quarter. The Series K is not entitled to any voting rights except as may be required by applicable law, and is not convertible into common stock. The Company has the right to redeem the Series K at any time while the Series K are outstanding at a price equal to the stated value plus any accrued but unpaid dividends. The Company is required to redeem the Series K two years following the date that is the later of the (i) final closing of the tranche (as designated in the applicable subscription agreement) or (ii) the expiration date of the tranche that such shares to be redeemed were a part of. The Company is required to redeem such shares of Series K between August 5, 2021 and April 24, 2022, at a price equal to the stated value plus any accrued but unpaid dividends. The issuances of the shares were accounted for under ASC 480-10-25-4, which requires liability treatment for certain mandatorily redeemable financial instruments, and the cumulative dividends are recorded as interest expense. During the three months ended March 31, 2022, the Company redeemed 63.5 shares of Series K preferred stock equal to the stated value of $63,500 and exchanged an aggregate of 35 shares of Series K preferred stock for 35 shares of Series W preferred stock. The shares were issued and exchanged within the terms of the agreement and no gain or loss was recognized. As of March 31, 2022, there were 482 shares of Series K preferred stock issued and outstanding which the Company was required to, and failed to redeem between August 5, 2021 and March 26, 2022, and was and remains in default for an aggregate redemption price (equal to the stated value) of $482,150. Series L On June 3, 2019, the Company designated 100,000 shares of preferred stock as Series L. The Series L has a stated value of $1,000 per share and holders are entitled to receive dividends on an as-converted basis with the Company’s common stock. The Series L preferred stock is convertible into shares of the Company’s common stock, on the terms and conditions set forth in the Series L COD, which includes certain make-good shares for certain prior investors. During the three months ended March 31, 2022, the Company issued an aggregate of 14,528,106 shares of common stock upon conversion of 124 shares of Series L preferred stock, for a loss in the amount of $210,997. As of March 31, 2022, there were 486 shares of Series L preferred stock issued and outstanding. Series M On July 1, 2020, the Company designated 800,000 shares of its preferred stock as Series M. Each share of Series M has a stated value of $25. The Series M is not convertible into common stock. The holders of outstanding shares of Series M are entitled to receive dividends, at the annual rate of 10%, payable monthly, payable in preference and priority to any payment of any dividend on the common stock. The Series M is entitled to a liquidation preference in an amount equal to $25 per share plus any declared but unpaid dividends, before any payments to holders of common stock. The Series M have no pre-emptive or subscription rights, and there are no sinking fund provisions applicable to the Series M. The Series M does not have voting rights, except as required by law and with respect to certain protective provisions set forth in the Certificate of Designation of Series M preferred stock. To the extent it may lawfully do so, the Company may, in its sole discretion, at any time when there are outstanding shares of Series M, redeem any or all of the then outstanding shares of Series M at a redemption price of $37.50 per share (150% of the stated value) plus any accrued but unpaid dividends. As of March 31, 2022, there were 40,300 shares of Series M preferred stock issued and outstanding. Series O On April 27, 2020, the Company designated 2,000 shares of preferred stock as Series O. The Series O has a stated value of $1,000 per share, and entitles holders to receive cumulative dividends (i) in cash at an annual rate of 8% of the stated value, and (ii) in shares of common stock of the Company (valued based on the conversion price as in effect on the last trading day of the applicable fiscal quarter) at an annual rate of 4% of the stated value, payable quarterly within 60 days from the end of such fiscal quarter. The Series O has a liquidation preference equal to the stated value plus any accrued but unpaid dividends, in preference to the common stock. The Series O has no preemptive or subscription rights, and there is no sinking fund provision applicable to the Series O. The Series O does not have voting rights except as required by law. The Series O is convertible into common stock of the Company in an amount determined by dividing 200% of the stated value of the Series O being converted by the conversion price, provided that, the Series O may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice). The conversion price is equal to the average closing sale price of the common stock for the five trading days prior to the conversion date. The Company has the right (but no obligation) to redeem the Series O at any time while the Series O are outstanding at a redemption price equal to the stated value plus any accrued but unpaid dividends. During the three months ended March 31, 2022, the Company issued an aggregate of 261,707 shares of common stock in prorated 4% annualized dividends which are recorded as interest expense. As of March 31, 2022, there were 615 shares of Series O preferred stock issued and outstanding. Series P On April 27, 2020, the Company designated 500 shares of preferred stock as Series P. The Series P has a stated value of $1,000 per share, and entitles holders to receive dividends on an as-converted basis with the Company’s common stock. The Series P is convertible into shares of the Company’s common stock, on the terms and conditions set forth in the Certificate of Designation of Series P preferred stock, which includes certain make-good shares for certain prior investors, and provided that, the Series P may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice). The Series P entitles the holders to a payment on an as-converted and pari passu basis with the common stock upon any liquidation. The Series P has no preemptive or subscription rights, and there is no sinking fund or redemption provisions applicable to the Series P. The Series P votes on an as-converted basis with the common stock, subject to the beneficial ownership limitation. As of March 31, 2022, there were 57.5 shares of Series P preferred stock issued and outstanding. Series Q On August 21, 2020, the Company designated 2,000 shares of preferred stock as Series Q. The Series Q has a stated value of $1,000 per share, and entitles holders to receive cumulative dividends in cash at an annual rate of 12% of the stated value, payable quarterly within 60 days from the end of such fiscal quarter. The Series Q has a liquidation preference equal to the stated value plus any accrued but unpaid dividends, in preference to the common stock. The Series Q has no preemptive or subscription rights, and there is no sinking fund provision applicable to the Series Q. The Series Q does not have voting rights except as required by law. The Series Q is convertible into common stock of the Company in an amount determined by dividing 200% of the stated value of the Series Q being converted by the conversion price, provided that, the Series Q may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice). The conversion price will be equal to the average closing sale price of the common stock for the five trading days prior to the conversion date. The Company has the right (but no obligation) to redeem the Series Q at any time while the Series Q are outstanding at a redemption price equal to the stated value plus any accrued but unpaid dividends. The cumulative dividends are recorded as interest expense. During the three months ended March 31, 2022, the Company exchanged 100 shares of Series F preferred stock for 100 shares of Series Q preferred stock. The shares were issued and exchanged within the terms of the agreement and no gain or loss was recognized. As of March 31, 2022, there were 615 shares of Series Q preferred stock issued and outstanding. Series R On November 16, 2020, the Company designated 5,000 shares of preferred stock as Series R. The Series R has a stated value of $1,000 per share, and entitles holders to receive cumulative dividends in cash at an annual rate of 10% of the stated value, payable quarterly within 60 days from the end of such fiscal quarter. The Series R holders are not entitled to any voting rights except as may be required by applicable law. The Series R is convertible into common stock of the Company in an amount determined by dividing 200% of the stated value of the Series R being converted by the conversion price; certain prior investors are also entitled to certain make-good shares; provided that, the Series R may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice). The conversion price will be equal to the average closing sale price of the common stock for the five trading days prior to the conversion date. The Company has the right (but no obligation) to redeem the Series R at any time while the Series R are outstanding at a redemption price equal to, if paid in cash, the stated value plus any accrued but unpaid cash dividends, or, if paid in shares of common stock, in an amount of shares determined by dividing the stated value being redeemed by the conversion price. The subscribers were offered warrants with the purchase of Series R. During the three months ended March 31, 2022, the Company issued an aggregate of 27,162,453 shares of common stock upon conversion of 378 shares of Series R preferred stock. The shares were issued and exchanged within the terms of the agreement and no gain or loss was recognized. As of March 31, 2022, there were 3,054 shares of Series R preferred stock along with 101,498,340 Series A warrants (with an exercise price of $0.05) and 49,177,670 Series B warrants (with an exercise price of $0.10) issued and outstanding with a fair value of $11,181,822 on the original issuance. The warrants were valued using the Black Scholes model (see additional information under warrants footnote). Series S On February 5, 2021, the Company designated 430 shares of preferred stock as Series S. The Series S has a stated value of $1,000 per share, and entitles holders to receive cumulative dividends in cash at an annual rate of 12% of the stated value, payable quarterly within 60 days from the end of such fiscal quarter. The Series S holders are not entitled to any voting rights except as may be required by applicable law. The Series S is convertible into common stock of the Company in an amount determined by dividing 200% of the stated value of the Series S being converted by the conversion price, provided that, the Series S may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice). The conversion price is equal to the average closing sale price of the common stock for the five trading days prior to the conversion date. The Company has the right (but no obligation) to redeem the Series S at any time while the Series S are outstanding at a redemption price equal to the stated value plus any accrued but unpaid dividends. As of March 31, 2022, there were 170 shares of Series S preferred stock issued and outstanding. Series T On February 24, 2021, the Company designated 630 shares of preferred stock as Series T. The Series T has a stated value of $1,000 per share, and entitles holders to receive cumulative dividends in cash at an annual rate of 10% of the stated value, payable monthly. The Series T holders are not entitled to any voting rights except as may be required by applicable law. The Series T is convertible into common stock of the Company pursuant to the Series T COD, provided that, the Series T may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice). The Company will have the right (but no obligation) to redeem the Series T at any time while the Series T are outstanding at a redemption price equal to the stated value plus any accrued but unpaid dividends. On March 1, 2021, the Company issued an aggregate of 630 shares of Series T Preferred Stock to an accredited investor (the “Purchaser’’) per terms of a Securities Purchase Agreement (the “SPA”). Per the SPA, the Company agreed to sell to Purchaser, and Purchaser agreed to purchase from the Company, 630 shares of the Company’s Series T, and two-year cashless warrants to acquire 25,200,000 shares of the Company’s common stock, valued at $0.05 per share per terms of the SPA, which may be exercised at any time in whole or in part. Per the SPA, the Series T, including any convertible shares acquired pursuant to exercise of the warrants, the Company shall pay 10% annual dividends in cash, paid monthly. Purchaser may convert any portion of the Series T, including convertible shares acquired pursuant to exercise of the warrants, at any time into shares of the Company’s common stock at an agreed upon conversion rate per terms of the SPA. The purchaser and the Company agreed that in lieu of the purchase price for the Series T, the Purchaser transferred to the Company real property, with an aggregate value agreed to be $630,000 based on an appraisal from an international independent company. The real property consists of residential real estate in Buenos Aires Argentina valued at $580,000, and eight undeveloped lots valued at $50,000 in Terralta private neighborhood development. The real property exchanged for 630 shares of Series T was recorded at $630,000 and reflected on the balance sheet as a long term asset for sale. The fair value of the warrants associated with acquiring 25,200,000 preferred shares were valued at $2,037,849, using the Black Scholes model and accounted for as deemed dividends and reflected in stockholder’s equity as accumulated paid in capital. The Company has actively listed the residential real property for sale since July 2021. On September 13, 2021, the Company received an offer for the property for $464,000, which was $116,000 below the original independent appraisal of $580,000. Based on that indicator of impairment, during the year ended December 31, 2021, the Company adjusted the original value of the long term asset for sale from $630,000 to $514,000 on the balance sheet and recorded an impairment of $116,000 in the consolidated financial statements. During the three months ended March 31, 2022, the Company issued an aggregate of 17,193,676 shares of common stock upon conversion of 145 shares of Series T preferred stock. As of March 31, 2022, there were 485 shares of Series T preferred stock issued and outstanding. Series U On May 26, 2021, the Company designated 5,000 shares of preferred stock as Series U. The Series U has a stated value of $1,000 per share. The Series U holders are not entitled to any dividends and do not have any voting rights except as may be required by applicable law. The Series U is convertible into common stock of the Company in an amount determined by dividing 150% of the stated value of the Series U being converted by the conversion price; certain prior investors are also entitled to certain make-good shares; provided that, the Series U may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice). The conversion price is equal to the lesser of $0.20 or the average closing sale price of the common stock for the five trading days prior to the conversion date. The Company has the right (but no obligation) to redeem the Series U at any time at a redemption price equal to, if paid in cash, the stated value, or, if paid in shares of common stock, in an amount of shares determined by dividing 200% of the stated value being redeemed by the conversion price then in effect, and adding any applicable make-good shares. During the three months ended March 31, 2022, the Company issued an aggregate of 22,794,493 shares of common stock upon conversion of 432 shares of Series U preferred stock. The shares were issued within the terms of the agreement and no gain or loss was recognized. As of March 31, 2022, there were 635 shares of Series U preferred stock issued and outstanding, along with 18,115,000 Series A warrants (with an exercise price of $0.05), 6,246,000 Series B warrants (with an exercise price of $0.10), and 1,561,000 Series C warrants (with an exercise price of $1.00) issued and outstanding with a fair value of $828,186 on the original issuance. The warrants were valued using the Black Scholes model (see additional information under warrants footnote). Series V On December 1, 2021, the Company filed a certificate of withdrawal of the Company’s certificate of designation of Series V preferred stock and filed a certificate of designation for a new series of Series V preferred stock with the Secretary of State of Nevada. Pursuant to the Series V COD, the Company designated 3,000 shares of preferred stock as Series V. The Series V has an original issue price of $100,000 per share, and holders are entitled to an annual distribution of 25% of annual net profits of newly established Company wholly-owned, Water On Demand subsidiaries, designated by each holder, paid within 3 months of subsidiary’s accounting year-end. The Series V holders are not entitled to any dividends and do not have any voting rights except as may be required by applicable law . The Series V is convertible into common stock of the Company pursuant to the Series V COD, provided that, the Series V may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice). The Company has the right (but no obligation) to redeem the Series V at any time at a redemption price equal to, if paid in cash, the stated value plus any accrued but unpaid distributions of 25% of subsidiary’s annual net profits. Series W On April 28, 2021, the Company designated 3,390 shares of preferred stock as Series W. The Series W has a stated value of $1,000 per share, and Series W holders are entitled to cumulative dividends in cash at an annual rate of 12% of the stated value, payable quarterly. The Series W holders are not entitled to any voting rights except as may be required by applicable law. The Series W is convertible into common stock of the Company in an amount determined by dividing 200% of the stated value of the Series W being converted by the conversion price; provided that, the Series W may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock. The conversion price will be equal to the average closing sale price of the common stock for the five trading days prior to the conversion date. The Company has the right (but no obligation) to redeem the Series W at any time at a redemption price equal to the stated value plus any accrued but unpaid dividends. During the three months ended March 31, 2022, the Company issued 35 shares of Series W preferred stock in exchange for 35 shares of Series K preferred stock and issued an aggregate of 694,446 shares of common stock upon conversion of 10 shares of Series W preferred stock. The shares were issued within the terms of the agreement and no gain or loss was recognized. As of March 31, 2022, there were 770 shares of Series W preferred stock issued and outstanding. Series X On August 10, 2021, the Company designated 25 shares of preferred stock as Series X. The Series X has a stated value of $10,000 per share. The Series X holders are not entitled to any dividends and do not have any voting rights except as may be required by applicable law. The Series X is convertible into common stock of the Company pursuant to the Series X COD, provided that, the Series X may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which amount may be increased up to 9.99% upon 61 days’ written notice). Beginning on the one year anniversary of the subscription agreement for the Series X Preferred Stock, until the two year anniversary of the subscription agreement, the holders will have the right to require the Company to redeem all of the Series X purchased by the subscriber at a price equal to 125% of the $250,000 original purchase price, or $312,500. The holders also have the right, exercisable at any time, to require the Company to redeem all of the holder’s Series X in exchange for the issuance of shares of the Company’s common stock in an amount equal to 250% of the original $250,000 purchase price, or $625,000, divided by the closing price of the Company’s common stock as of the date the holders executed the subscription agreement. On August 10, 2021, the Company issued and sold to an accredited investor an aggregate of 25 shares of Series X preferred stock for a purchase price of $250,000. Per the Series X COD, as of March 31, 2022, $140,000 of the $250,000 was classified as restricted cash. As of March 31, 2022, there were 25 shares of Series X preferred stock issued and outstanding. Series Y On December 6, 2021, the Company designated 3,000 shares of preferred stock as Series Y. The Series Y has an original issue price of $100,000 per share, and holders are entitled to receive, on a pro rata and pari passu basis, annual distribution of 25% of annual net profits of newly established, wholly-owned, Water On Demand subsidiaries, designated by each holder, paid within 3 months of subsidiary’s accounting year-end. The Series Y holders are not entitled to any voting rights except as may be required by applicable law. The Series Y is convertible into common stock of the Company pursuant to the Series Y COD, provided that, the Series Y may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice). The Company has the right (but no obligation) to redeem the Series Y at any time at a redemption price equal to, if paid in cash, the original issue price plus any accrued but unpaid distributions of 25% of the subsidiary’s annual net profits. During the three months ended March 31, 2022, the Company issued 12.5 shares of Series Y preferred stock at an original issue price of $1,244,200 and issued an aggregate of 9,953,600 warrants with a fair value of $270,385 to Series Y holders, and issued 4 shares of Series Y preferred stock in exchange for 4 shares of Series V for an aggregate value of $400,000 and issued an aggregate of 3,200,000 warrants with a fair value of $97,507 to those Series Y preferred stock investors. Per the Series Y COD, $622,100 of the $1,244,200 received was classified as restricted cash. As of March 31, 2022, there were 21.1 shares of Series Y preferred stock issued and outstanding, along with 16,913,600 warrants (with an exercise price of $0.05) and 6,246,000 Series B warrants (with an exercise price of $0.10) issued and outstanding with a fair value of $1,561,500 on the original issuance. The warrants were valued using the Black Scholes model (see additional information under warran

Restricted Stock and Warrants

Restricted Stock and Warrants	3 Months Ended
	Mar. 31, 2022
Share-Based Payment Arrangement [Abstract]
RESTRICTED STOCK AND WARRANTS	4. RESTRICTED STOCK AND WARRANTS Restricted Stock to CEO Between May 12, 2016, and January 1, 2022, the Company entered into Restricted Stock Grant Agreements (“the RSGAs”) with its Chief Executive Officer, Riggs Eckelberry, to create management incentives to improve the economic performance of the Company and to increase its value and stock price. All shares issuable under the RSGAs are performance based shares. The RSGAs provides for the issuance of up to an aggregate of 242,109,214 shares of the Company’s common stock to Mr. Eckelberry provided certain milestones are met in certain stages; a) If the Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period as reported in the Company’s quarterly or annual financial statements, the Company will issue up to an aggregate of 121,054,607 shares of its common stock; b) If the Company’s consolidated operating profit ( Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization 121,054,607 Restricted Stock to the Board, Employees and Consultants Between May 12, 2016, and January 1, 2022, the Company entered into Restricted Stock Grant Agreements (“the BEC RSGAs”) with its members of the Board, employees, and consultants to create management incentives to improve the economic performance of the Company and to increase its value and stock price. All shares issuable under the BEC RSGAs are performance based shares. The BEC RSGAs provide for the issuance of up to 356,141,542 shares of the Company’s common stock to employees and consultants provided certain milestones are met in certain stages; a) If the Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period as reported in the Company’s quarterly or annual financial statements, the Company will issue up to an aggregate of 178,070,771 shares of its common stock; b) If the Company’s consolidated operating profit Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), 178,070,771 On August 14, 2019, the Board of Directors approved an amendment to the RSGAs and BEC RSGAs to include an alternative vesting schedule for the Grantees and on January 26, 2022, the Company amended the procedures for processing the RSGAs and BEC RSGAs. Once a G rantee is eligible to participate in alternate vesting, then they will be added to the list of alternate vestees, enlarging the pool of vestees among which, 10% of stock sales that are allowed under the agreement is divided for the next year. The Company then (i) calculates the value of the Company common stock traded in the year immediately prior to the vesting year, using daily adjusted close and volume, as quoted on the public securities trading market on which the Company’s common stock is then traded (ii) determines the cost basis of the shares, which shall be the closing price quoted on the public securities trading market, quoted on the first trading day of the vesting year which will be the grantee’s cost basis, and (iii) applies the 10% calculation and divides it into the number of qualifying alternate vestees, giving the gross number of shares available to each Grantee. For each alternate vestee for each year in which there occurs a vesting or a potential vesting, the Company (i) does a 90-day lookback from the first day of the latest vesting month, to limit cumulative vesting of shares for each alternate vestee for the 90-day period to 1% of total Company shares of common stock outstanding for the period, using the then current figure for shares outstanding at the time of the lookback; (ii) places the excess shares (the “Overlimit Shares”) in suspense for issuance in the next 90-day period so that in each future 90-day period they may be issued, and (iii) if on the 90-day lookback, cumulative issuances are less than 1% of shares outstanding, the Company will add the shares from previous 90-day lookback, if any. For the avoidance of doubt, the Company will not record any Overlimit Shares as vested until such as time as they have been finally issued. During the three months ended March 31, 2022, the Company did not issue any shares relating to the RSGAs nor the BEC RSGAs. Warrants During the three months ended March 31, 2022, the Company granted 15,653,600 common stock purchase warrants, associated with the issuance of preferred stock. A summary of the Company’s warrant activity and related information follows for the three months ended March 31, 2022: 3/31/2022 Number of Weighted Outstanding - beginning of period 217,085,783 $ 0.0868 Granted 15,653,600 $ 0.1210 Exercised - - Expired (50,076,010 ) $ 0.0736 Outstanding - end of period 182,663,373 $ 0.0893 At March 31, 2022, the weighted average remaining contractual life of warrants outstanding: 2022 Weighted Remaining Exercisable Warrants Warrants Contractual Prices Outstanding Exercisable Life (years) $ 0.02 600,000 600,000 4.42 $ 0.05 90,175,000 90,175,000 0.01 - 0.92 $ 0.10 58,440,000 58,440,000 0.01 - 1.65 $ 0.25 10,006,000 10,006,000 1.25 – 4.75 $ 0.0275 8,727,273 8,727,273 9.16 $ 0.125 13,153,600 13,153,600 4.77 - 4.99 $ 1.00 1,561,500 1,561,500 2.25 - 2.72 182,663,373 182,663,373 At March 31, 2022, the aggregate intrinsic value of the warrants outstanding was $0.

Convertible Promissory Notes

Convertible Promissory Notes	3 Months Ended
	Mar. 31, 2022
Debt Disclosure [Abstract]
CONVERTIBLE PROMISSORY NOTES	5. CONVERTIBLE PROMISSORY NOTES As of March 31, 2022, the outstanding convertible promissory notes are summarized as follows: Convertible Promissory Notes $ 3,012,155 Less current portion 1,596,008 Total long-term liabilities $ 1,416,147 Maturities of long-term debt for the next two years are as follows: Year Ending March 31, Amount 2023 1,596,008 2024 1,312,275 2025 103,772 $ 3,012,155 On various dates from November 2014 through April 2015, the Company issued unsecured convertible promissory notes (the “2014-2015 Notes”), that matured on various dates and were extended sixty (60) months from the effective date of each Note. The 2014-2015 Notes bear interest at 10% per year. The maturity dates were extended to November 2023 through April 2024. The 2014-2015 Notes may be converted into shares of the Company’s common stock at conversion prices ranging from the lesser of $4,200 to $9,800 (subject to adjustment for stock splits, dividends, combinations and other similar transactions) or 50% of the lowest trade price on any trade day following issuance of the 2014-2015 Notes. In addition, for as long as the 2014-2015 Notes or other convertible notes in effect between the purchaser and the Company are outstanding, if the Company issues any security with terms more favorable than the terms of the 2014-2015 Notes or such other convertible notes or a term was not similarly provided to the purchaser of the 2014-2015 Notes or such other convertible notes, then such more favorable or additional term shall, at the purchaser’s option, become part of the 2014-2015 Notes and such other convertible notes. The conversion feature of the 2014-2015 Notes was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the 2014-2015 Notes. During the three months ended March 31, 2022, the Company issued 12,461,909 shares of common stock, upon conversion of $69,900 in principal, plus accrued interest of $49,734. As of March 31, 2022, the 2014-2015 Notes had an aggregate remaining balance of $860,100, which are long term. The unsecured convertible promissory notes (the “OID Notes”) had an aggregate remaining balance of $184,124, plus accrued interest of $13,334. The OID Notes included an original issue discount and one-time interest, which has been fully amortized. The OID Notes matured on December 31, 2017, which were extended to June 30, 2023. The OID Notes were convertible into shares of the Company’s common stock at a conversion price initially of $30,620. After the amendment, the conversion price changed to the lesser of $5,600 per share, or b) fifty percent (50%) of the lowest trade price of common stock recorded since the original effective date of this note, or c) the lowest effective price per share granted to any person or entity after the effective date. The conversion feature of the notes was considered a derivative in accordance with current accounting guidelines, because of the reset conversion features of the notes. As of March 31, 2022, the remaining balance was $62,275, which is long term. The Company issued various, unsecured convertible promissory notes (the “2015Notes”), on various dates ending on August 2015. The 2015 Notes matured and were extended from the date of each tranche through maturity dates ending on February 2024 through March 2024, and April 2022 through August 2022. The 2015 Notes bear interest at 10% per year. The 2015 Notes may be converted into shares of the Company’s common stock at conversion prices ranging from the lesser of $1,400 to $5,600 (subject to adjustment for stock splits, dividends, combinations and other similar transactions) or 50% of the lowest trade price on any trade day following issuance of the 2015 Notes. The conversion feature of the 2015 Notes was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the 2015 Notes. As of March 31, 2022, the 2015 Notes had an aggregate remaining balance of $1,200,000, of which $780,000 is short term and $420,000 is long term. The Company issued a convertible note (the “Dec 2015 Note”) in exchange for accounts payable in the amount of $432,048, which could be converted into shares of the Company’s common stock after December 31, 2015. The Dec 2015 Note was accounted for under ASC 470, whereby, a beneficial conversion feature was recorded at time of issuance. The Dec 2015 Note did not meet the criteria of a derivative, and was accounted for as a beneficial conversion feature, which was amortized over the life of the Dec 2015 Note and recognized as interest expense in the financial statements. On January 1, 2016, the Dec 2015 Note met the criteria of a derivative and was accounted for under ASC 815. The Dec 2015 Note has zero stated interest rate, and the conversion price shall be equal to 75% of the average three lowest last sale prices traded during the 25 trading days immediately prior to conversion. As of March 31, 2022, the remaining balance on the Dec 2015 Note was $167,048, which is short term. The Company issued a convertible note (the “Sep 2016 Note”) in exchange for accounts payable in the amount of $430,896, which could be converted into shares of the Company’s common stock after September 15, 2016. The Sep 2016 Note was accounted for under ASC 470, whereby, a beneficial conversion feature was recorded at time of issuance. The Sep 2016 Note met the criteria of a derivative and was accounted for under ASC 815. The Sep 2016 Note has zero stated interest rate, and the conversion price shall be equal to 75% of the average three lowest last sale prices traded during the 25 trading days immediately prior to conversion. The Sep 2016 Note did not meet the criteria of a derivative at the date of the issuance, and was accounted for as a beneficial conversion feature, which was amortized over the life of the Sep 2016 Note and recognized as interest expense in the financial statements. The conversion feature of the Sep 2016 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion feature of the Sep 2016 Note. As of March 31, 2022, the remaining balance on the Sep 2016 Note was $430,896, which is short term. The Company issued two (2) unsecured convertible promissory notes (the “Apr & May 2018 Notes”), in the aggregate amount of $300,000 on April 2, 2018 and May 31, 2018. The Apr & May 2018 Notes had maturity dates of April 2, 2019 and May 31, 2019, respectively. The Apr & May 2018 Notes bear interest at 10% per year. The Apr & May 2018 Notes may be converted into shares of the Company’s common stock at a variable conversion price of 50% of the lesser of the lowest trading price twenty-five (25) trading days prior to conversion. The conversion feature of the Apr & May 2018 Notes was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Notes. On March 13, 2019, the Company entered into a settlement agreement with the investor in the amount of $570,000, based on the outstanding balance due and payable under the Apr & May 2018 Notes. The Company set up a reserve of 2,630,769 shares of common stock of the Company for issuance upon conversion by the investor of the amounts owed under the Notes, in accordance with the terms of the Notes, including, but not limited to the beneficial ownership limitations contained in the Notes. In addition to the foregoing, upon the sale by the investor of the settlement shares as delivered to the investor by the Company, resulting in total net proceeds less than the settlement value, the investor is entitled to additional settlement shares of the Company’s common stock. If after the investor has sold all settlement shares, the investor delivers a written notice to the Company certifying that the investor is entitled to additional settlement shares of the Company’s common stock (the “Make-Whole Shares”). The number of make-whole shares being equal to the greater of ((i) zero and (ii) the quotient of (1) the difference of (x) the settlement value with respect to each sale of shares by the Investor after the delivery of the Settlement Shares, minus (y) the aggregate net consideration received by the Investor from the resale of all shares of common stock issued by the Company, divided by (2) the average trailing closing price for ten (10) trading days for the shares immediately preceding the date of delivery of the make-whole shares. As of March 31, 2022, the remaining balance on the May 2018 Note was $218,064, which is short term. The Company entered into an unsecured convertible promissory note (the “Nov 20 Note”), on November 19, 2020 in the amount of $50,000. The Company received funds in the amount of $50,000. The Nov 20 Note matures on November 19, 2021, twelve months from the effective date of the Note. The Note may be extended sixty (60) months from the maturity date. The Nov 20 Note bears interest at 10% per year. The Nov 20 Note may be converted into shares of the Company’s common stock at a lesser price of $0.05 per share or (b) fifty percent (50%) of the lowest trade price of common stock recorded on any trade after the effective date, or (c) the lowest effective price per share granted. In addition, for each conversion, in event that shares are not delivered by the fourth business day (inclusive of the day of conversion), a penalty of $2,000 per day shall be assessed for each day after the third business day until the shares are delivered. The conversion feature of the Nov 20 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Note. As of March 31, 2022, the remaining balance on the Nov 20 Note was $13,772, which is long term. The Company entered into an unsecured convertible promissory note (the “Jan 21 Note”), on January 25, 2021 in the amount of $60,000. The Company received funds in the amount of $60,000. The Jan 21 Note matures on January 25, 2022, twelve months from the effective date of the Note. The Note may be extended sixty (60) months from the maturity date. The Jan 21 Note bears interest at 10% per year. The Jan 21 Note may be converted into shares of the Company’s common stock at a conversion price equal to the lower of (a) $0.05 per share, (b) fifty percent (50%) of the lowest trade price of common stock recorded on any trade after the effective date, or (c) the lowest effective price per share granted. In addition, for each conversion, in event that shares are not delivered by the fourth business day (inclusive of the day of conversion), a penalty of $2,000 per day shall be assessed for each day after the third business day until the shares are delivered. The conversion feature of the Jan 25 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Note. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $3,743 during the three months ended March 31, 2022. As of March 31, 2022, the balance of the Jan 21 Note was $60,000, which is long term. We evaluated the financing transactions in accordance with ASC Topic 815, Derivatives and Hedging, and determined that the conversion feature of the convertible promissory notes was not afforded the exemption for conventional convertible instruments due to its variable conversion rate. The note has no explicit limit on the number of shares issuable, so they did not meet the conditions set forth in current accounting standards for equity classification. The Company elected to recognize the note under paragraph 815-15-25-4, whereby, there would be a separation into a host contract and derivative instrument. The Company elected to initially and subsequently measure the note in its entirety at fair value, with changes in fair value recognized in earnings. The Company recorded a derivative liability representing the imputed interest associated with the embedded derivative. The derivative liability is adjusted periodically according to the stock price fluctuations. The derivative liability recognized in the financial statements as of March 31, 2022 was $7,852,842.

Revenue from Contracts with Cus

Revenue from Contracts with Customers	3 Months Ended
	Mar. 31, 2022
Revenue from Contracts with Customers [Abstract]
REVENUE FROM CONTRACTS WITH CUSTOMERS	6. REVENUE FROM CONTRACTS WITH CUSTOMERS Equipment Contracts Revenues and related costs on equipment contracts are recognized as the performance obligations for work are satisfied over time in accordance with Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers. Under ASC 606, revenue and associated profit will be recognized as the customer obtains control of the goods and services promised in the contract (i.e., performance obligations). All un-allocable indirect costs and corporate general and administrative costs are charged to the periods as incurred. However, in the event a loss on a contract is foreseen, the Company will recognize the loss as it is determined. The following table represents a disaggregation of revenue by type of good or service from contracts with customers for the March 31, 2022 and 2021. Three Months Ended March 31, 2022 2021 Equipment Contracts $ 812,245 $ 502,441 Component Sales 354,731 265,135 Waste Water Treatment Systems 49,460 - Rental Income 6,573 8,114 Services Sales 11,096 20,488 $ 1,234,105 $ 796,178 Revenue recognition for other sales arrangements, such as sales for components, and service sales will remain materially consistent. Contract assets represents revenues recognized in excess of amounts billed on contracts in progress. Contract liabilities represents billings in excess of revenues recognized on contracts in progress. Assets and liabilities related to long-term contracts are included in current assets and current liabilities in the accompanying balance sheets, as they will be liquidated in the normal course of the contract completion. The contract asset for the three months ended March 31, 2022 and the year ended December 31, 2021, was $781,967 and $378,932, respectively. The contract liability for the three months ended March 31, 2022, and the year ended December 31, 2021, was $2,494,825 and $1,886,946, respectively.

Financial Assets

Financial Assets	3 Months Ended
	Mar. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
FINANCIAL ASSETS	7. FINANCIAL ASSETS Fair value investment in Securities On November 12, 2021, the Company served a conversion notice to WTII and recorded additional interest and fees of $15,988 through that date, according to the terms of the securities purchase agreement for an aggregate of $149,867. The Note was converted into 45,208,649 shares of WTII common stock. As of March 31, 2022, the investment in securities was recorded at fair value in the amount of $94,940, with an unrealized loss of $103,978. On May 15, 2018, the Company received 4,000 shares of WTII Series C convertible preferred stock for the use of OriginClear, Inc. technology associated with their proprietary electro water separation system. Each share of Series C convertible preferred stock is convertible into one thousand (1,000) shares of WTII common stock. The stock was valued at fair market value of $0.0075 for a price of $30,000 on the date of issuance. The Company analyzed the licensing agreement using ASU 606 to determine the timing of revenue recognition. The licensing of the intellectual property (IP) is distinct from the non-license goods or services and has significant standalone functionality that provides a benefit or value. The functionality will not change during the license period due to the licensor’s activities. Because the significant standalone functionality was delivered immediately, the revenue was recognized in the financial statements as of June 30, 2018. As of March 31, 2022, the fair value of the preferred shares was $8,800.

Loans Payable

Loans Payable	3 Months Ended
	Mar. 31, 2022
Loans Payable Disclosure [Abstract]
LOANS PAYABLE	8. LOANS PAYABLE Secured Loans Payable The Company entered into short term loans with various lenders for capital expansion secured by the Company’s assets in the amount of $1,749,970, which included finance cost of $624,810. The finance cost was amortized over the terms of the loans, which have various maturity dates ranging from October 2018 through February 2019. As of December 31, 2020, the finance cost was fully amortized. During the year ended December 31, 2021, the Company settled the majority of the loans in the amount of $262,250, of which $157,250 was recognized on the statement of operations as a gain on write-off of loan payable. The term of the loans ranged from two months to six months. During the period ended March 31, 2022, the Company received $25,000 as a settlement and wrote off $50,000 of secured loans payable. The net balance as of March 31, 2022 was $30,646. Small Business Administration Loans Between April 30, 2020 and September 12, 2020, the Company received total loan proceeds in the amount of $505,000, which included an aggregate of $345,000 under the Paycheck Protection Program (the “PPP”) under the Coronavirus Aid, Relief and Economic Security Act, an Economic Injury Disaster Loan (the “EIDL”) in the amount of $150,000, and an Economic Injury Disaster Grant in the amount of $10,000. The principal and accrued interest under the PPP was forgivable if the Company used the PPP loan proceeds for eligible purposes, including payroll, benefits, rent and utilities, and otherwise complied with PPP requirements. The Company used the full proceeds of the PPP loan specifically for eligible purposes per requirements of the PPP and during the period ending December 31, 2021, the Company submitted satisfactory documentation regarding its compliance with the applicable requirements and obtained forgiveness of the PPP loan. The Company must repay any unforgiven principal amount, with interest, on a monthly basis following the deferral period for the EIDL. For the period ended December 31, 2021, the aggregate amount of $345,000 received under the PPP, and the Economic Injury Disaster Grant in the amount of $10,000 was recognized in the statement of operations as other income due to forgiveness.

Capital Leases

Capital Leases	3 Months Ended
	Mar. 31, 2022
Capital Leases [Abstract]
CAPITAL LEASES	9. CAPITAL LEASES The Company entered into a capital lease for the purchase of equipment during the year ended December 31, 2018. The lease is for a sixty (60) month term, with monthly payments of $757 per month, and a purchase option at the end of the lease for $1.00. As of March 31, 2022, there remain a current balance of $5,713.

Foreign Subsidiary

Foreign Subsidiary	3 Months Ended
	Mar. 31, 2022
Foreign Subsidiary [Abstract]
FOREIGN SUBSIDIARY	10. FOREIGN SUBSIDIARY On January 22, 2020 the Company entered into a strategic partnership with Permionics Separations Solutions, Inc., a unit of India’s Permionics Group (“Permionics”) for the Asia-Pacific Region. This strategic partnership assists the Company with overcoming the typical hurdles in commercializing a technology overseas with engineering support, developing customer proposals, infrastructure to handle logistics and purchasing, inventory and shipping from and into foreign countries, customer training, startup assistance and service. The Company believes that Permionics is best suited to accomplish all of the above for its customers in the Asia-Pacific countries and as a result, has terminated all activities of its fully owned subsidiary, OriginClear Technologies Limited, in Hong Kong, China, working instead with Permionics when applicable.

Assets Held For Sale

Assets Held For Sale	3 Months Ended
	Mar. 31, 2022
Property, Plant and Equipment Assets Held-for-sale Disclosure [Abstract]
ASSETS HELD FOR SALE	11. ASSETS HELD FOR SALE The Company acquired real estate assets to be held for sale to finance their water projects, by issuing 630 shares of Series T preferred stock for a fair value of $630,000, in conjunction with common stock purchase warrants, through an asset purchase agreement. The assets held for sale consisted of residential property, plus eight (8) lots of undeveloped land. The real property has been listed actively on the market to be sold. Based on the offers received and the market conditions, the Company adjusted the fair value by $116,000 leaving a fair value of $514,000.

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	12. COMMITMENTS AND CONTINGENCIES Facility Rental – Related Party Our Dallas based subsidiary, PWT, rents an approximately12,000 square foot facility located at 2535 E. University Drive, McKinney, TX 75069, with a current monthly rent of $7,900. Warranty Reserve Generally, a PWT project is guaranteed against defects in material and workmanship for one year from the date of completion, while certain areas of construction and materials may have guarantees extending beyond one year. The Company has various insurance policies relating to the guarantee of completed work, which in the opinion of management will adequately cover any potential claims. A warranty reserve has been provided under PWT based on the opinion of management and based on Company history in the amount of $20,000 for the three months ended March 31, 2022. Litigation On January 24, 2022, OriginClear, Inc., Progressive Water Treatment, Inc., OriginClear, Inc., and T. Riggs Eckelberry, individually (collectively, the “GTR Plaintiffs”), on the one hand, and GTR Source LLC and Tzvi “Steve” Reich (collectively, the “GTR Defendants”), on the other hand, settled a dispute between the parties relating to two distinct merchant funding agreements that were entered into on July 20, 2018 and August 28, 2018, and a settlement agreement entered into on December 13, 2018. Pursuant to the terms of settlement, all of which have been performed as of the filing date, (i) the GTR Defendants paid $25,000 to the GTR Plaintiffs, (ii) the parties mutually released each other from all claims, controversies, etc. that could have been asserted by any party against any other party pursuant to the aforesaid merchant funding agreements and settlement entered thereunder, and (iii) the GTR Plaintiffs dismissed with prejudice the action commenced by the GTR Plaintiffs in the Supreme Court for the State of New York in and for the County of Ontario and the appeal in the United States Court of Appeals for the Second Circuit. In addition the foregoing terms of settlement, on January 11, 2022, the GTR Defendants filed a vacatur of the judgment by confession, with prejudice, that was obtained in favor of the GTR Defendants and against the GTR Plaintiffs in the Supreme Court for the State of New York in and for the County of Ontario. As of the filing date, the Company views the aforesaid GTR matter as closed. On March 12, 2021, OriginClear, Inc. Progressive Water Treatment, Inc. and T. Riggs Eckelberry, individually (collectively, the “C6 Plaintiffs”), and C6 Capital LLC (“C6 Capital”) agreed to settle the dispute between the parties relating to a merchant cash advance agreement entered into on July 17, 2018. Pursuant to the terms of the settlement, (i) C6 has vacated the judgment obtained by C6 Capital against the C6 Plaintiffs; (ii) C6 has released any and all bank levies, liens, security interests, powers of attorney, and other encumbrances its has against the C6 Plaintiffs; (iii) the C6 Plaintiffs have dismissed the plenary action commenced in the Supreme Court for the State of New York in and for the County of Broome against C6 Capital with prejudice and; (iv) the sister-state judgment C6 Capital obtained against the C6 Plaintiffs in California is currently in the process of being vacated by stipulation. Accordingly, the C6 Plaintiffs no longer owe any further amounts to C6 Capital with respect to the C6 Agreement. On February 12, 2019, Auctus Fund, LLC (“Auctus”) filed a complaint against OriginClear in the United States District Court for the District of Massachusetts for numerous claims arising from two convertible promissory notes and accompanying securities purchase agreements. On March 13, 2019, Auctus and OriginClear entered into a Settlement Agreement and Mutual General Release, under which Auctus would be permitted to convert $570,000 into OriginClear securities pursuant to the terms set forth in the convertible promissory notes. On February 2, 2021, OriginClear filed a Motion to Set Aside the Settlement Agreement as Void under Section 29(b) of the Securities Exchange Act of 1934 (the “Act”) for Auctus’ violation of Section 15(a) of the Act. If granted, the Settlement Agreement would be declared void and unenforceable. As of the filing date, no decision has been rendered on OriginClear’s Motion to Set Aside the Settlement Agreement.

Subsequent Events

Subsequent Events	3 Months Ended
	Mar. 31, 2022
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	13. SUBSEQUENT EVENTS Management has evaluated subsequent events according to the requirements of ASC TOPIC 855 and has determined that there are the following subsequent events: On April 6, 2022, OriginClear agreed in principle to an arrangement with Houston-based, international water service company Envirogen Technologies (www.envirogen.com), a 30-year international provider of environmental technology and process solutions, to deliver and maintain OriginClear’s Water On Demand fully-outsourced industrial and agriculture systems. Between April 6, 2022 and May 10, 2022, the Company entered into subscription agreements with certain accredited investors pursuant to which the Company sold an aggregate of 6.25 shares of the Company’s Series Y preferred stock for an aggregate purchase price of $625,000. The Company also issued an aggregate of 5,000,000 warrants to these investors. On April 13, 2022, the Company’s Board of Directors approved the plan to spin off its Water On Demand business into a newly formed wholly-owned subsidiary, Water On Demand Inc., which will hold the assets, liabilities, intellectual property and business operations of the Water On Demand business. The Board also approved the issuance of rights to receive shares in Water On Demand Inc. as a bonus to the purchasers of its Series Y Preferred Shares, which are currently being offering pursuant to a private placement. On April 18, 2022, holders of the Company’s Series K preferred stock exchanged an aggregate of 50 shares of Series K preferred stock for 50 shares of the Company’s Series W preferred stock. Between April 18, 2022 and May 2, 2022, the Company issued to consultants an aggregate of 4,565,014 shares of the Company’s common stock for services. On April 18, 2022, the Company entered into settlement agreements with certain accredited investors pursuant to which the Company issued an aggregate of 18,731,644 shares of the Company’s common stock in settlement of certain claims with such persons. Between April 19, 2022 and May 11, 2022, holders of the Company’s Series W preferred stock converted an aggregate of 35 Series W shares into an aggregate of 3,117,364 shares of the Company’s common stock. On April 19, 2022, a prior holder of the Company’s Series P preferred stock was issued an aggregate of 518,232 shares of the Company’s common stock as a make-good for a prior Series P conversion. On April 25, 2022, holders of the Company’s Series T preferred stock converted an aggregate of 60 Series T shares into an aggregate of 9,230,770 shares of the Company’s common stock. On April 25, 2022, holders of the Company’s Series Y preferred stock converted an aggregate of 50 Series Y shares into an aggregate of 4,230,769 shares of the Company’s common stock. On April 26, 2022, holders of the Company’s Series L preferred stock converted an aggregate of 10 Series L shares into an aggregate of 1,445,086 shares, including make-good shares, of the Company’s common stock. On April 26, 2022, holders of the Company’s Series R preferred stock converted an aggregate of 20 Series R shares into an aggregate of 2,504,816 shares, including make-good shares, of the Company’s common stock. On May 10, 2022, holders of the Company’s Series I preferred stock exchanged an aggregate of 10 shares of Series I preferred stock for 10 shares of the Company’s Series W preferred stock. On May 11, 2022, holders of the Company’s Series J preferred stock converted an aggregate of 5 Series J shares into an aggregate of 512,737 shares, including make-good shares, of the Company’s common stock.

Accounting Policies, by Policy

Accounting Policies, by Policy (Policies)	3 Months Ended
	Mar. 31, 2022
Accounting Policies [Abstract]
Principles of Consolidation	Principles of Consolidation The accompanying consolidated financial statements include the accounts of OriginClear, Inc. and its wholly owned operating subsidiaries, Progressive Water Treatment, Inc., and OriginClear Technologies, Ltd. All material intercompany transactions have been eliminated upon consolidation of these entities.
Cash and Cash Equivalent	Cash and Cash Equivalent The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include estimates used to review the Company’s impairments and estimations of long-lived assets, revenue recognition on percentage of completion type contracts, allowances for uncollectible accounts, warranty reserves, inventory valuation, derivative liabilities and other conversion features, fair value investments, valuations of non-cash capital stock issuances and the valuation allowance on deferred tax assets. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable in the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.
Net Earnings (Loss) per Share Calculations	Net Earnings (Loss) per Share Calculations Basic loss per share calculation is computed by dividing income (loss) available to common shareholders by the weighted-average number of common shares available. Diluted earnings per share is computed similarly to basic earnings per share except that the denominator is increased to include securities or other contracts to issue common stock that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. The Company’s diluted earnings per share were not the same as the basic loss per share for the three months ended March 31, 2022 and 2021, respectively, as the inclusion of any potential shares in the three months ended March 31, 2022 and 2021, would have had an anti-dilutive effect due to the Company generating a loss. For the Three Months 2022 2021 Income (Loss) to common shareholders (Numerator) $ (3,576,267 ) $ (19,895,424 ) Basic weighted average number of common shares outstanding (Denominator) 416,397,236 91,595,414 Diluted weighted average number of common shares outstanding (Denominator) 416,397,236 91,595,414 The Company excludes issuable shares from warrants, convertible notes and preferred stock, if their impact on the loss per share is anti-dilutive and includes the issuable shares if their impact is dilutive.
Revenue Recognition	Revenue Recognition We recognize revenue when services are performed, and at the time of shipment of products, provided that evidence of an arrangement exists, title and risk of loss have passed to the customer, fees are fixed or determinable, and collection of the related receivable is reasonably assured. Revenues and related costs on construction contracts are recognized as the performance obligations for work are satisfied over time in accordance with Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers. Under ASC 606, revenue and associated profit, will be recognized as the customer obtains control of the goods and services promised in the contract (i.e., performance obligations). All un-allocable indirect costs and corporate general and administrative costs are charged to the periods as incurred. However, in the event a loss on a contract is foreseen, the Company will recognize the loss as it is determined. Revisions in cost and profit estimates during the course of the contract are reflected in the accounting period in which the facts for the revisions become known. Provisions for estimated losses on uncompleted contracts are made in the period in which such losses are determined. Changes in job performance, job conditions, and estimated profitability, including those arising from contract penalty provisions, and final contract settlements, may result in revisions to costs and income, which are recognized in the period the revisions are determined. Contract receivables are recorded on contracts for amounts currently due based upon progress billings, as well as retention, which are collectible upon completion of the contracts. Accounts payable to material suppliers and subcontractors are recorded for amounts currently due based upon work completed or materials received, as are retention due subcontractors, which are payable upon completion of the contract. General and administrative expenses are charged to operations as incurred and are not allocated to contract costs.
Contract Receivable	Contract Receivable The Company bills its customers in accordance with contractual agreements. The agreements generally require billing to be on a progressive basis as work is completed. Credit is extended based on evaluation of clients’ financial condition and collateral is not required. The Company maintains an allowance for doubtful accounts for estimated losses that may arise if any customer is unable to make required payments. Management performs a quantitative and qualitative review of the receivables past due from customers on a monthly basis. The Company records an allowance against uncollectible items for each customer after all reasonable means of collection have been exhausted, and the potential for recovery is considered remote. The allowance for doubtful accounts was $0 and $0 as of March 31, 2022 and December 31, 2021, respectively. The net contract receivable balance was $1,039,746 and $2,150,967 at March 31, 2022 and December 31, 2021, respectively.
Indefinite Lived Intangibles and Goodwill Assets	Indefinite Lived Intangibles and Goodwill Assets The Company accounts for business combinations under the acquisition method of accounting in accordance with ASC 805, “Business Combinations,” where the total purchase price is allocated to the tangible and identified intangible assets acquired and liabilities assumed based on their estimated fair values. The purchase price is allocated using the information currently available, and may be adjusted, up to one year from acquisition date, after obtaining more information regarding, among other things, asset valuations, liabilities assumed and revisions to preliminary estimates. The purchase price in excess of the fair value of the tangible and identified intangible assets acquired less liabilities assumed is recognized as goodwill. The Company tests for indefinite lived intangibles and goodwill impairment in the fourth quarter of each year and whenever events or circumstances indicate that the carrying amount of the asset exceeds its fair value and may not be recoverable. In accordance with its policies, the Company performed a qualitative assessment of indefinite lived intangibles and goodwill at March 31, 2022 and determined there was no impairment of indefinite lived intangibles and goodwill.
Property and Equipment	Property and Equipment Property and equipment are stated at cost. Gain or loss is recognized upon disposal of property and equipment, and the asset and related accumulated depreciation are removed from the accounts. Expenditures for maintenance and repairs are charged to expense as incurred, while expenditures for addition and betterment are capitalized. Furniture and equipment are depreciated on the straight-line method and include the following categories: Estimated Life Machinery and equipment 5-10 years Furniture, fixtures and computer equipment 5-7 years Vehicles 3-5 years Leasehold improvements 2-5 years 3/31/2022 12/31/21 Machinery and Equipment $ 383,569 $ 383,569 Computer Equipment 62,854 62,854 Furniture 29,810 29,810 Leasehold Improvements 26,725 26,725 Vehicles 64,276 64,276 Demo Units 36,139 36,139 603,373 603,373 Less accumulated depreciation (400,715 ) (389,982 ) Net Property and Equipment $ 202,658 $ 213,391 Long-lived assets held and used by the Company are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. In the event that the facts and circumstances indicate that the cost of any long-lived assets may be impaired, an evaluation of recoverability would be performed following generally accepted accounting principles. Depreciation expense during the three months ended March 31, 2022 and March 31, 2021, was $10,733 and $11,631, respectively.
Inventory	Inventory The Company expenses inventory on a first in, first out basis, and had raw materials of $2,850 and $2,850 as of March 31, 2022 and December 31, 2021, respectively.
Stock-Based Compensation	Stock-Based Compensation The Company periodically issues stock options and warrants to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for stock option and warrant grants issued and vesting to employees based on the authoritative guidance provided by the Financial Accounting Standards Board whereas the value of the award is measured on the date of grant and recognized over the vesting period. The Company accounts for stock option and warrant grants issued and vesting to non-employees in accordance with the authoritative guidance of the Financial Accounting Standards Board whereas the value of the stock compensation is based upon the measurement date as determined at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. Non-employee stock-based compensation charges generally are amortized over the vesting period on a straight-line basis. In certain circumstances where there are no future performance requirements by the non-employee, option grants vest immediately and the total stock-based compensation charge is recorded in the period of the measurement date.
Accounting for Derivatives	Accounting for Derivatives The Company evaluates all its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. For stock-based derivative financial instruments, the Company uses a probability weighted average series Binomial lattice option pricing models to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not the net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date.
Fair Value of Financial Instruments	Fair Value of Financial Instruments Fair Value of Financial Instruments requires disclosure of the fair value information, whether or not to recognized in the balance sheet, where it is practicable to estimate that value. As of March 31, 2022, the balances reported for cash, contract receivables, cost in excess of billing, prepaid expenses, accounts payable, billing in excess of cost, and accrued expenses approximate the fair value because of their short maturities. We adopted ASC Topic 820 for financial instruments measured as fair value on a recurring basis. ASC Topic 820 defines fair value, established a framework for measuring fair value in accordance with accounting principles generally accepted in the United States and expands disclosures about fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 established a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include: ● Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets; ● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and ● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. The following table presents certain investments and liabilities of the Company’s financial assets measured and recorded at fair value on the Company’s balance sheets on a recurring basis and their level within the fair value hierarchy as of March 31, 2022. Total (Level 1) (Level 2) (Level 3) Investment at fair value-securities $ 94,940 $ 94,940 $ - $ - Total Assets measured at fair value $ 94,940 $ 94,940 $ - $ - Total (Level 1) (Level 2) (Level 3) Derivative Liability, March 31, 2022 $ 7,852,842 $ - $ - $ 7,852,842 Total liabilities measured at fair value $ 7,852,842 $ - $ - $ 7,852,842 The following is a reconciliation of the derivative liability for which level 3 inputs were used in determining the approximate fair value: Balance as of January 1, 2022 $ 6,526,129 Fair value at issuance - Loss on conversion of debt and change in derivative liability 1,326,713 Balance as of March 31, 2022 $ 7,852,842 For purpose of determining the fair market value of the derivative liability, the Company used Binomial lattice formula valuation model. The significant assumptions used in the Binomial lattice formula valuation of the derivative are as follows: 3/31/22 Risk free interest rate 0.17% - 2.45 % Stock volatility factor 20.0% - 190.0 % Weighted average expected option life 6 months - 5 years Expected dividend yield None
Segment Reporting	Segment Reporting The Company’s business currently operates in one segment based upon the Company’s organizational structure and the way in which the operations are managed and evaluated.
Marketable Securities	Marketable Securities The Company adopted ASU 2016-01, “Financial Instruments – Recognition and Measurement of Financial Assets and Financial Liabilities.” ASU 2016-01 requires investments (except those accounted for under the equity method of accounting, or those that result in consolidation of the investee) to be measured at fair value with changes in fair value recognized in net income. It requires public business entities to use the exit price notion when measuring the fair value of financial instruments for disclosure purpose, and separate presentation of financial assets and financial liabilities by measurement category and form of financial asset. It eliminates the requirement for public business entities to disclose the method(s) and significant assumptions used to estimate the fair value that is required to be disclosed for financial instruments measured at amortized cost. The Company has evaluated the potential impact this standard may have on the condensed consolidated financial statements and determined that it had a significant impact on the condensed consolidated financial statements. The Company accounts for its investment in Water Technologies International, Inc. as available-for-sale securities, and the unrealized gain on the available-for-sale securities is recognized in net income.
Licensing agreement	Licensing agreement The Company analyzed the licensing agreement using ASU 606 to determine the timing of revenue recognition. The licensing of the intellectual property (IP) is distinct from the non-license goods or services and has significant standalone functionality that provides a benefit or value. The functionality will not change during the license period due to the licensor’s activities. Because the significant standalone functionality is delivered immediately, the revenue is generally recognized when the license is delivered.
Work-in-Process	Work-in-Process The Company recognizes as an asset the accumulated costs for work-in-process on projects expected to be delivered to customers. Work in Process includes the cost price of materials and labor related to the construction of equipment to be sold to customers.
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements Management reviewed currently issued pronouncements and does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the accompanying condensed financial statements.

Summary of Significant Accoun_2

Summary of Significant Accounting Polices (Tables)	3 Months Ended
	Mar. 31, 2022
Accounting Policies [Abstract]
Schedule of loss per share anti-dilutive effect	For the Three Months 2022 2021 Income (Loss) to common shareholders (Numerator) $ (3,576,267 ) $ (19,895,424 ) Basic weighted average number of common shares outstanding (Denominator) 416,397,236 91,595,414 Diluted weighted average number of common shares outstanding (Denominator) 416,397,236 91,595,414
Schedule of estimated useful life	Estimated Life Machinery and equipment 5-10 years Furniture, fixtures and computer equipment 5-7 years Vehicles 3-5 years Leasehold improvements 2-5 years
Schedule of property plant and equipment	3/31/2022 12/31/21 Machinery and Equipment $ 383,569 $ 383,569 Computer Equipment 62,854 62,854 Furniture 29,810 29,810 Leasehold Improvements 26,725 26,725 Vehicles 64,276 64,276 Demo Units 36,139 36,139 603,373 603,373 Less accumulated depreciation (400,715 ) (389,982 ) Net Property and Equipment $ 202,658 $ 213,391
Schedule of fair value of financial instruments	Total (Level 1) (Level 2) (Level 3) Investment at fair value-securities $ 94,940 $ 94,940 $ - $ - Total Assets measured at fair value $ 94,940 $ 94,940 $ - $ - Total (Level 1) (Level 2) (Level 3) Derivative Liability, March 31, 2022 $ 7,852,842 $ - $ - $ 7,852,842 Total liabilities measured at fair value $ 7,852,842 $ - $ - $ 7,852,842
Schedule of reconciliation of the derivative liability for which level 3 inputs	Balance as of January 1, 2022 $ 6,526,129 Fair value at issuance - Loss on conversion of debt and change in derivative liability 1,326,713 Balance as of March 31, 2022 $ 7,852,842
Schedule of fair market value of derivative liability assumptions	3/31/22 Risk free interest rate 0.17% - 2.45 % Stock volatility factor 20.0% - 190.0 % Weighted average expected option life 6 months - 5 years Expected dividend yield None

Restricted Stock and Warrants (

Restricted Stock and Warrants (Tables)	3 Months Ended
	Mar. 31, 2022
Share-Based Payment Arrangement [Abstract]
Schedule of warrant activity	3/31/2022 Number of Weighted Outstanding - beginning of period 217,085,783 $ 0.0868 Granted 15,653,600 $ 0.1210 Exercised - - Expired (50,076,010 ) $ 0.0736 Outstanding - end of period 182,663,373 $ 0.0893
Schedule of weighted average remaining contractual life of warrants outstanding	2022 Weighted Remaining Exercisable Warrants Warrants Contractual Prices Outstanding Exercisable Life (years) $ 0.02 600,000 600,000 4.42 $ 0.05 90,175,000 90,175,000 0.01 - 0.92 $ 0.10 58,440,000 58,440,000 0.01 - 1.65 $ 0.25 10,006,000 10,006,000 1.25 – 4.75 $ 0.0275 8,727,273 8,727,273 9.16 $ 0.125 13,153,600 13,153,600 4.77 - 4.99 $ 1.00 1,561,500 1,561,500 2.25 - 2.72 182,663,373 182,663,373

Convertible Promissory Notes (T

Convertible Promissory Notes (Tables)	3 Months Ended
	Mar. 31, 2022
Debt Disclosure [Abstract]
Schedule of outstanding convertible promissory notes	Convertible Promissory Notes $ 3,012,155 Less current portion 1,596,008 Total long-term liabilities $ 1,416,147
Schedule of maturities of long-term debt	Year Ending March 31, Amount 2023 1,596,008 2024 1,312,275 2025 103,772 $ 3,012,155

Revenue from Contracts with C_2

Revenue from Contracts with Customers (Tables)	3 Months Ended
	Mar. 31, 2022
Revenue from Contracts with Customers [Abstract]
Schedule of disaggregation of revenue by type of good or service from contracts with customers	Three Months Ended March 31, 2022 2021 Equipment Contracts $ 812,245 $ 502,441 Component Sales 354,731 265,135 Waste Water Treatment Systems 49,460 - Rental Income 6,573 8,114 Services Sales 11,096 20,488 $ 1,234,105 $ 796,178

Basis of Presentation (Details)

Basis of Presentation (Details)	3 Months Ended
	Mar. 31, 2022USD ($)
Accounting Policies [Abstract]
Capital amount	$ 1,000,000
Revenue	$ 1,234,105

Summary of Significant Accoun_3

Summary of Significant Accounting Polices (Details) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Accounting Policies [Abstract]
Allowance for doubtful accounts	$0		$0
Contract receivable	$ 1,039,746		$ 2,150,967
Depreciation expense	10,733	$ 11,631
Raw materials	$ 2,850		$ 2,850
Derivative term of contract	12 months

Summary of Significant Accoun_4

Summary of Significant Accounting Polices (Details) - Schedule of loss per share anti-dilutive effect - USD ($)	3 Months Ended			12 Months Ended
	Dec. 31, 2022	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Schedule of loss per share anti-dilutive effect [Abstract]
Income (Loss) to common shareholders (Numerator) (in Dollars)	$ (3,576,267)			$ (19,895,424)
Basic weighted average number of common shares outstanding (Denominator)	416,397,236	416,397,236	91,595,414	91,595,414
Diluted weighted average number of common shares outstanding (Denominator)	416,397,236			91,595,414

Summary of Significant Accoun_5

Summary of Significant Accounting Polices (Details) - Schedule of estimated useful life	3 Months Ended
	Mar. 31, 2022
Machinery and equipment [Member] | Minimum [Member]
Summary of Significant Accounting Polices (Details) - Schedule of estimated useful life [Line Items]
Estimated Life	5 years
Machinery and equipment [Member] | Maximum [Member]
Summary of Significant Accounting Polices (Details) - Schedule of estimated useful life [Line Items]
Estimated Life	10 years
Furniture, fixtures and computer equipment [Member] | Minimum [Member]
Summary of Significant Accounting Polices (Details) - Schedule of estimated useful life [Line Items]
Estimated Life	5 years
Furniture, fixtures and computer equipment [Member] | Maximum [Member]
Summary of Significant Accounting Polices (Details) - Schedule of estimated useful life [Line Items]
Estimated Life	7 years
Vehicles [Member] | Minimum [Member]
Summary of Significant Accounting Polices (Details) - Schedule of estimated useful life [Line Items]
Estimated Life	3 years
Vehicles [Member] | Maximum [Member]
Summary of Significant Accounting Polices (Details) - Schedule of estimated useful life [Line Items]
Estimated Life	5 years
Leasehold improvements [Member] | Minimum [Member]
Summary of Significant Accounting Polices (Details) - Schedule of estimated useful life [Line Items]
Estimated Life	2 years
Leasehold improvements [Member] | Maximum [Member]
Summary of Significant Accounting Polices (Details) - Schedule of estimated useful life [Line Items]
Estimated Life	5 years

Summary of Significant Accoun_6

Summary of Significant Accounting Polices (Details) - Schedule of property plant and equipment - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Property, Plant and Equipment [Line Items]
Gross Property and Equipment	$ 603,373	$ 603,373
Less accumulated depreciation	(400,715)	(389,982)
Net Property and Equipment	202,658	213,391
Machinery and Equipment [Member]
Property, Plant and Equipment [Line Items]
Gross Property and Equipment	383,569	383,569
Computer Equipment [Member]
Property, Plant and Equipment [Line Items]
Gross Property and Equipment	62,854	62,854
Furniture [Member]
Property, Plant and Equipment [Line Items]
Gross Property and Equipment	29,810	29,810
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Gross Property and Equipment	26,725	26,725
Vehicles [Member]
Property, Plant and Equipment [Line Items]
Gross Property and Equipment	64,276	64,276
Demo Units [Member]
Property, Plant and Equipment [Line Items]
Gross Property and Equipment	$ 36,139	$ 36,139

Summary of Significant Accoun_7

Summary of Significant Accounting Polices (Details) - Schedule of fair value of financial instruments	Mar. 31, 2022USD ($)
Summary of Significant Accounting Polices (Details) - Schedule of fair value of financial instruments [Line Items]
Investment at fair value-securities	$ 94,940
Total Assets measured at fair value	94,940
Derivative Liability	7,852,842
Total liabilities measured at fair value	7,852,842
Level 1 [Member]
Summary of Significant Accounting Polices (Details) - Schedule of fair value of financial instruments [Line Items]
Investment at fair value-securities	94,940
Total Assets measured at fair value	94,940
Derivative Liability
Total liabilities measured at fair value
Level 2 [Member]
Summary of Significant Accounting Polices (Details) - Schedule of fair value of financial instruments [Line Items]
Investment at fair value-securities
Total Assets measured at fair value
Derivative Liability
Total liabilities measured at fair value
Level 3 [Member]
Summary of Significant Accounting Polices (Details) - Schedule of fair value of financial instruments [Line Items]
Investment at fair value-securities
Total Assets measured at fair value
Derivative Liability	7,852,842
Total liabilities measured at fair value	$ 7,852,842

Summary of Significant Accoun_8

Summary of Significant Accounting Polices (Details) - Schedule of reconciliation of the derivative liability for which level 3 inputs	3 Months Ended
	Mar. 31, 2022USD ($)
Schedule of reconciliation of the derivative liability for which level 3 inputs [Abstract]
Balance	$ 6,526,129
Fair value at issuance
Loss on conversion of debt and change in derivative liability	1,326,713
Balance	$ 7,852,842

Summary of Significant Accoun_9

Summary of Significant Accounting Polices (Details) - Schedule of fair market value of derivative liability assumptions	3 Months Ended
	Mar. 31, 2022
Summary of Significant Accounting Polices (Details) - Schedule of fair market value of derivative liability assumptions [Line Items]
Expected dividend yield	0.00%
Minimum [Member]
Summary of Significant Accounting Polices (Details) - Schedule of fair market value of derivative liability assumptions [Line Items]
Risk free interest rate	0.17%
Stock volatility factor	20.00%
Weighted average expected option life	6 months
Maximum [Member]
Summary of Significant Accounting Polices (Details) - Schedule of fair market value of derivative liability assumptions [Line Items]
Risk free interest rate	2.45%
Stock volatility factor	190.00%
Weighted average expected option life	5 years

Capital Stock (Details)

Capital Stock (Details) - USD ($)	May 11, 2022	Feb. 11, 2022	Dec. 06, 2021	Dec. 01, 2021	Nov. 12, 2021	Aug. 10, 2021	May 26, 2021	Apr. 28, 2021	Mar. 01, 2021	Feb. 24, 2021	Feb. 05, 2021	Nov. 16, 2020	Aug. 21, 2020	Jul. 01, 2020	Apr. 27, 2020	Jun. 03, 2019	Apr. 03, 2019	Jan. 16, 2019	Aug. 14, 2018	Apr. 13, 2018	Mar. 14, 2017	Feb. 18, 2022	Jun. 10, 2021	Feb. 24, 2021	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021	Apr. 18, 2022	Apr. 30, 2021	Dec. 31, 2020
Capital Stock (Details) [Line Items]
Redemption of preferred stock																							$235,000
Redeem shares																									482			18,731,644
Aggregate of shares																									482,150
Conversion of shares	512,737
Exercise price (in Dollars per share)																									$ 0.1
Fair value of original issuance (in Dollars)																									$ 828,186
Common stock par value (in Dollars per share)																									$ 0.0001		$ 0.0001
Sale of property, description																									On September 13, 2021, the Company received an offer for the property for $464,000, which was $116,000 below the original independent appraisal of $580,000. Based on that indicator of impairment, during the year ended December 31, 2021, the Company adjusted the original value of the long term asset for sale from $630,000 to $514,000 on the balance sheet and recorded an impairment of $116,000 in the consolidated financial statements.
Shares issued																									526,305,492		306,883,932
Preferred stock and warrants																									12.5
Preferred stock outstanding																									635
Warrants shares (in Dollars)																									$ 6,246,000
Common stock shares outstanding																									526,305,492		306,883,932
Restricted cash (in Dollars)																									$ 1,061,227		$ 433,951
Fair value (in Dollars)																									$ 630,000
Common stock, shares, outstanding percentage		4.99%
Number of warrants shares																						2,500,000
Aggregate principal amount (in Dollars)					$ 149,867
Interest amount (in Dollars)																										$ 23,507
Common stock issued for services, shares																									13,314,289
Common stock issued for services fair value (in Dollars)																									$ 338,724
Fair value (in Dollars)																									11,101
Aggregate principal amount (in Dollars)																									$ 25,000
Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Shares outstanding																									33,038,213	34,038,213	33,038,213			34,038,213
Warrants shares (in Dollars)																									$ 16,913,600
Common Stock [Member]
Capital Stock (Details) [Line Items]
Shares outstanding																									526,305,492	112,898,030	306,883,932			65,052,688
Redeem shares																									12,461,909
Aggregate purchase price (in Dollars)																									$ 119,634
Common stock share issued																									12,461,909
Aggregate principal amount (in Dollars)																									$ 69,900
Interest amount (in Dollars)																									$ 49,734
Conversion price (in Dollars per share)																									$ 0.00955
Common stock issued for services, shares																										4,766,280
Common stock issued for services fair value (in Dollars)																										$ 339,119
Shares issued																									111,010,481
Common stock of convertible promissory notes																										6,354,895
Aggregate principal amount (in Dollars)																										$ 37,500
Issuance of common stock, shares																									1,041,662
Maximum [Member]
Capital Stock (Details) [Line Items]
Conversion price (in Dollars per share)																									$ 0.0319
Share prices ranging (in Dollars per share)																										$ 0.0351
Minimum [Member]
Capital Stock (Details) [Line Items]
Conversion price (in Dollars per share)																									$ 0.0235
Share prices ranging (in Dollars per share)																										0.124
Minimum [Member] | Common Stock [Member]
Capital Stock (Details) [Line Items]
Conversion price (in Dollars per share)																										$ 0.00955
Series W Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Aggregate preferred stock, share issued																									10
Series C Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Preferred stock per share (in Dollars per share)																					$ 0.0001
Voting power																					51%
Purchase price of the series C preferred stock (in Dollars per share)																					$ 0.1
Total purchase price series C preferred stock, shares																					1,000
Preferred stock shares outstanding																									1,000
Preferred stock, share authorized																									550,000,000		550,000,000
Preferred stock and warrants																									1,000		1,000
Preferred stock per share (in Dollars per share)																									$ 0.0001		$ 0.0001
Preferred stock outstanding																									1,000		1,000
Series D-1 Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Preferred stock, share authorized																				50,000,000
Convertible preferred stock, per share (in Dollars per share)																				$ 0.0005
Percentage of common stock outstanding																				4.99%
Increased common stock percentage																				9.99%
Preferred stock issued and outstanding																									31,500,000
Preferred stock and warrants																									31,500,000
Series E Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Preferred stock, share authorized																			4,000,000
Convertible preferred stock, per share (in Dollars per share)																			$ 0.05
Percentage of common stock outstanding																			4.99%
Increased common stock percentage																			9.99%
Preferred stock issued and outstanding																									1,537,213
Preferred stock and warrants																									1,537,213		1,537,213
Preferred stock outstanding																									1,537,213		1,537,213
Issuance of common stock, shares																										36,487,963
Common stock upon conversion of preferred stock																										1,251
Series F Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Preferred stock shares outstanding																											260
Designated preferred stock issued																			6,000
Preferred stock liquidation per share (in Dollars per share)																			$ 1,000
Annual rate percentage																			8.00%
Preferred stock, description																											a holder of 100 of such outstanding shares of Series F preferred stock, agreed that the Company would have no obligation to redeem such holder’s shares of Series F preferred stock prior to September 1, 2022. On February 14, 2022, the Company exchanged those 100 shares of the holder’s Series F preferred stock for 100 shares of Series Q preferred stock. As of March 31, 2022, the Company had 160 outstanding shares of Series F preferred stock, which the Company was required to, and failed to redeem on September 1, 2020, and was and remains in default for an aggregate redemption price (equal to the stated value) of $160,000.
Aggregate preferred stock, share issued																									100
Series G Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Shares issued																									25
Designated preferred stock issued																		6,000
Annual rate percentage																		8.00%
Preferred stock per share (in Dollars per share)																		$ 1,000
Divided closing price (in Dollars)																		$ (500)
Shares outstanding																													25,000
Series I Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Shares issued																									235
Preferred stock per share (in Dollars per share)																	$ 1,000
Preferred stock and warrants																									235		235
Designated preferred stock issued																	4,000
Dividend rate, percentage																	8.00%
Preferred stock outstanding																									235		235
Series I Preferred Stock [Member] | Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Preferred stock and warrants																									35
Series J Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Preferred stock per share (in Dollars per share)																	$ 1,000
Preferred stock issued and outstanding																									215
Designated preferred stock issued																	100,000
Series K Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Preferred stock per share (in Dollars per share)																$ 1,000
Preferred stock and warrants																									482		581
Designated preferred stock issued																4,000
Purchase price of shares																									35
Preferred stock outstanding																									482		581
Series K Preferred Stock [Member] | Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Preferred stock and warrants																									35
Series M Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Preferred stock issued and outstanding																									40,300
Designated preferred stock issued														800,000
Dividend rate, percentage														10.00%		8.00%
Stated value (in Dollars)														$ 25
Liquidation preference value (in Dollars)														$ 25
Redemption price, per share (in Dollars per share)														$ 37.5
Stated value percentage														150.00%
Series R Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Shares issued																									3,054
Percentage of common stock outstanding												4.99%
Designated preferred stock issued												5,000
Preferred stock per share (in Dollars per share)												$ 1,000
Dividend rate, percentage												10.00%
Purchase price of shares																									63.5
Percentage of common stock												200.00%
Common stock outstanding increased percentage												9.99%
Aggregate purchase price																									27,162,453
Aggregate shares																									378
Exercise price (in Dollars per share)																									$ 0.05
Exercise price (in Dollars per share)																									$ 0.1
Series R Preferred Stock [Member] | Series A warrants [Member]
Capital Stock (Details) [Line Items]
Preferred warrants																									101,498,340
Series R Preferred Stock [Member] | Series B Warrants [Member]
Capital Stock (Details) [Line Items]
Preferred stock issued and outstanding																									49,177,670
Fair value of original issuance (in Dollars)																									$ 11,181,822
Series W Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Preferred stock and warrants								3,390
Annual rate percentage								12.00%
Preferred stock per share (in Dollars per share)								$ 1,000
Purchase price of shares																									35
Shares exchange																									63,500
Stated value percentage								200.00%
Outstanding common stock percentage								4.99%
Preferred stock issued and outstanding																									770
Series L Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Preferred stock per share (in Dollars per share)																$ 1,000
Preferred stock issued and outstanding																									486
Designated preferred stock issued																100,000
Conversion of preferred shares																									14,528,106
Conversion of shares																									124
Preferred stock loss amount (in Dollars)																									$ 210,997
Series O Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Preferred stock per share (in Dollars per share)															$ 1,000
Preferred stock issued and outstanding																									615
Designated preferred stock issued															2,000
Conversion of preferred shares																									261,707
Conversion price percentage															200.00%
Aggregate preferred stock, share issued																									0.04
Series O Preferred Stock [Member] | Common Stock [Member]
Capital Stock (Details) [Line Items]
Shares issued																										236,205
Common stock for preferred stock dividends payable																									261,707
Series O Preferred Stock [Member] | Maximum [Member]
Capital Stock (Details) [Line Items]
Annual rate percentage															8.00%
Outstanding common stock percentage															9.99%
Series O Preferred Stock [Member] | Minimum [Member]
Capital Stock (Details) [Line Items]
Annual rate percentage															4.00%
Outstanding common stock percentage															4.99%
Series P Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Increased common stock percentage															9.99%
Preferred stock issued and outstanding																									57.5
Designated preferred stock issued															500
Preferred stock per share (in Dollars per share)															$ 1,000
Percentage of common stock															4.99%
Series Q Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Percentage of common stock outstanding													4.99%
Preferred stock issued and outstanding																									615
Designated preferred stock issued													2,000
Preferred stock per share (in Dollars per share)													$ 1,000
Dividend rate, percentage													12.00%
Percentage of common stock													200.00%
Common stock outstanding increased percentage													9.99%
Aggregate shares (in Dollars)																									$ 100
Series S Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Preferred stock per share (in Dollars per share)											$ 1,000
Percentage of common stock outstanding											4.99%
Increased common stock percentage											9.99%
Preferred stock issued and outstanding																									170
Designated preferred stock issued											430
Dividend rate, percentage											12.00%
Percentage of common stock											200.00%
Series T Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Shares issued										630														630
Preferred stock per share (in Dollars per share)										$ 1,000														$ 1,000
Percentage of common stock outstanding										4.99%
Preferred stock and warrants										25,200,000														25,200,000
Designated preferred stock issued										630														630
Dividend rate, percentage										10.00%
Common stock outstanding increased percentage										9.99%
Aggregate shares (in Dollars)																									$ 17,193,676
Aggregate shares																									145
Common stock par value (in Dollars per share)									$ 0.05
Annual dividends, percentage									10.00%
Real property cost (in Dollars)									$ 630,000
Property consists of residential real estate (in Dollars)									580,000
Undeveloped lots valued (in Dollars)									$ 50,000
Long term asset for sale (in Dollars)										$ 630,000														$ 630,000
Preferred stock valued (in Dollars)																								$ 2,037,849
Preferred stock issued and outstanding																									485
Series U Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Percentage of common stock outstanding							4.99%
Designated preferred stock issued							5,000
Preferred stock per share (in Dollars per share)							$ 1,000
Conversion of preferred shares																									694,446
Percentage of common stock							150.00%
Common stock outstanding increased percentage							9.99%
Aggregate shares																									22,794,493
Common stock par value (in Dollars per share)							$ 0.2
Conversion price percentage							200.00%
Shares issued																									432
Preferred stock and warrants																									635
Series U Preferred Stock [Member] | Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Warrants shares (in Dollars)																									$ 18,115,000
Series A warrants [Member]
Capital Stock (Details) [Line Items]
Exercise price (in Dollars per share)																									$ 0.05
Series B Warrants [Member]
Capital Stock (Details) [Line Items]
Exercise price (in Dollars per share)																									$ 0.1
Warrants shares (in Dollars)																									$ 6,246,000
Series C warrants [Member]
Capital Stock (Details) [Line Items]
Exercise price (in Dollars per share)																									$ 1
Warrants shares (in Dollars)																									$ 1,561,000
Series V Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Percentage of common stock outstanding				4.99%
Designated preferred stock issued				3,000
Shares exchange																									4
Common stock outstanding increased percentage				9.99%
Fair value of original issuance (in Dollars)																									$ 3,200,000
Original issue price (in Dollars)				$ 100,000
Annual net profits percentage				25.00%
Subsidiary’s annual net profits percentage				25.00%
Issued shares																									4
Series Y Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Percentage of common stock outstanding			4.99%
Increased common stock percentage			9.99%
Preferred stock and warrants																									21.1
Designated preferred stock issued			3,000
Shares exchange																									4
Fair value of original issuance (in Dollars)																									$ 97,507
Preferred stock outstanding																									21.1
Restricted cash																									622,100
Original issue price (in Dollars)			$ 100,000																						$ 1,244,200
Fair value (in Dollars)																									270,385
Aggregate value of common stock (in Dollars)																									4
Aggregate value (in Dollars)																									$ 400,000
Warrants issued																									3,200,000
Restricted cash (in Dollars)																									$ 1,244,200
Amount of accrued dividends (in Dollars)																									352,359
Series Y Preferred Stock [Member] | Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Warrants shares (in Dollars)																									$ 9,953,600
Series W Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Increased common stock percentage						9.99%
Preferred stock issued and outstanding																									25
Designated preferred stock issued						25
Stated value (in Dollars)						$ 10,000
Percentage of common stock						250.00%
Shares issued																									82,373,174
Common stock shares outstanding						0.0499
Subscription agreement percentage						125.00%
Subscribed amount (in Dollars)						$ 250,000
Original purchase price (in Dollars)						312,500
Common stock purchase price (in Dollars)						250,000
Divided price (in Dollars)						$ 625,000
Sale of aggregate shares						25
Aggregate purchase price (in Dollars)						$ 250,000
Restricted cash																									140,000
Restricted cash (in Dollars)																									$ 250,000
Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Exercise price (in Dollars per share)																									$ 0.05
Fair value of original issuance (in Dollars)																									$ 1,561,500
Series Z Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Designated preferred stock issued		25
Annual rate percentage		25.00%
Common stock outstanding increased percentage		9.99%
Aggregate shares																						25
Original issue price (in Dollars)		$ 10,000
Fair value (in Dollars)																						$ 56,036
Preferred stock purchase price (in Dollars)																						$ 250,000
Securities Purchase Agreement [Member] | Series T Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Aggregate purchase price, shares									630
Agreed of purchase warrants									630
Number of acquire warrant shares									25,200,000
Board of Directors Chairman [Member] | Series C Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Shares issued																					1,000
Preferred stock per share (in Dollars per share)																					$ 0.0001

Restricted Stock and Warrants_2

Restricted Stock and Warrants (Details) - USD ($)	Jan. 02, 2022	Aug. 14, 2019	Mar. 31, 2022
Restricted Stock and Warrants (Details) [Line Items]
Restricted stock grant agreement, description	of up to 356,141,542 shares of the Company’s common stock to employees and consultants provided certain milestones are met in certain stages; a) If the Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period as reported in the Company’s quarterly or annual financial statements, the Company will issue up to an aggregate of 178,070,771 shares of its common stock; b) If the Company’s consolidated operating profit Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), calculated in accordance with generally accepted accounting principles, equals or exceeds $1,500,000 for the trailing twelve month period as reported as reported in the Company’s SEC reports, the Company will issue up to an aggregate of 178,070,771 shares of its common stock. The Company has not recognized any costs associated with the milestones, because achievement is not probable.
Board of directors amendment, description		The Company then (i) calculates the value of the Company common stock traded in the year immediately prior to the vesting year, using daily adjusted close and volume, as quoted on the public securities trading market on which the Company’s common stock is then traded (ii) determines the cost basis of the shares, which shall be the closing price quoted on the public securities trading market, quoted on the first trading day of the vesting year which will be the grantee’s cost basis, and (iii) applies the 10% calculation and divides it into the number of qualifying alternate vestees, giving the gross number of shares available to each Grantee. For each alternate vestee for each year in which there occurs a vesting or a potential vesting, the Company (i) does a 90-day lookback from the first day of the latest vesting month, to limit cumulative vesting of shares for each alternate vestee for the 90-day period to 1% of total Company shares of common stock outstanding for the period, using the then current figure for shares outstanding at the time of the lookback; (ii) places the excess shares (the “Overlimit Shares”) in suspense for issuance in the next 90-day period so that in each future 90-day period they may be issued, and (iii) if on the 90-day lookback, cumulative issuances are less than 1% of shares outstanding, the Company will add the shares from previous 90-day lookback, if any. For the avoidance of doubt, the Company will not record any Overlimit Shares as vested until such as time as they have been finally issued.
Number of purchase of warrants			15,653,600
Warrants outstanding			$ 0
Restricted Stock Grant Agreement [Member] | Employee Consultants and Restricted Stock Grant Agreements [Member]
Restricted Stock and Warrants (Details) [Line Items]
Issuance of common stock to employees	356,141,542
Aggregate of common stock, percentage		10.00%
Chief Executive Officer [Member] | Restricted Stock Grant Agreement [Member]
Restricted Stock and Warrants (Details) [Line Items]
Restricted stock grant agreement, description	The RSGAs provides for the issuance of up to an aggregate of 242,109,214 shares of the Company’s common stock to Mr. Eckelberry provided certain milestones are met in certain stages; a) If the Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period as reported in the Company’s quarterly or annual financial statements, the Company will issue up to an aggregate of 121,054,607 shares of its common stock; b) If the Company’s consolidated operating profit (Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), calculated in accordance with generally accepted accounting principles, equals or exceeds $1,500,000 for the trailing twelve month period as reported in the Company’s SEC Reports, the Company will issue up to an aggregate of 121,054,607 shares of its common stock.

Restricted Stock and Warrants_3

Restricted Stock and Warrants (Details) - Schedule of warrant activity - Warrant [Member]	3 Months Ended
	Mar. 31, 2022$ / sharesshares
Restricted Stock and Warrants (Details) - Schedule of warrant activity [Line Items]
Number of Warrants, Outstanding - beginning of period | shares	217,085,783
Weighted average exercise price, Outstanding - beginning of period | $ / shares	$ 0.0868
Number of Warrants, Granted | shares	15,653,600
Weighted average exercise price, Granted | $ / shares	$ 0.121
Number of Warrants, Exercised | shares
Weighted average exercise price, Exercised | $ / shares
Number of Warrants Expired | shares	(50,076,010)
Weighted average exercise price Expired | $ / shares	$ 0.0736
Number of Warrants, Outstanding - end of period | shares	182,663,373
Weighted average exercise price, Outstanding - end of period | $ / shares	$ 0.0893

Restricted Stock and Warrants_4

Restricted Stock and Warrants (Details) - Schedule of weighted average remaining contractual life of warrants outstanding	3 Months Ended
	Mar. 31, 2022$ / sharesshares
Class of Warrant or Right [Line Items]
Warrants Outstanding	182,663,373
Warrants Exercisable	182,663,373
0.02 [Member]
Class of Warrant or Right [Line Items]
Exercisable Prices (in Dollars per share) | $ / shares	$ 0.02
Warrants Outstanding	600,000
Warrants Exercisable	600,000
Weighted Average Remaining Contractual Life (years)	4 years 5 months 1 day
0.05 [Member]
Class of Warrant or Right [Line Items]
Exercisable Prices (in Dollars per share) | $ / shares	$ 0.05
Warrants Outstanding	90,175,000
Warrants Exercisable	90,175,000
0.10 [Member]
Class of Warrant or Right [Line Items]
Exercisable Prices (in Dollars per share) | $ / shares	$ 0.1
Warrants Outstanding	58,440,000
Warrants Exercisable	58,440,000
0.25 [Member]
Class of Warrant or Right [Line Items]
Exercisable Prices (in Dollars per share) | $ / shares	$ 0.25
Warrants Outstanding	10,006,000
Warrants Exercisable	10,006,000
0.0275 [Member]
Class of Warrant or Right [Line Items]
Exercisable Prices (in Dollars per share) | $ / shares	$ 0.0275
Warrants Outstanding	8,727,273
Warrants Exercisable	8,727,273
Weighted Average Remaining Contractual Life (years)	9 years 1 month 28 days
0.125 [Member]
Class of Warrant or Right [Line Items]
Exercisable Prices (in Dollars per share) | $ / shares	$ 0.125
Warrants Outstanding	13,153,600
Warrants Exercisable	13,153,600
1.00 [Member]
Class of Warrant or Right [Line Items]
Exercisable Prices (in Dollars per share) | $ / shares	$ 1
Warrants Outstanding	1,561,500
Warrants Exercisable	1,561,500
Minimum [Member] | 0.05 [Member]
Class of Warrant or Right [Line Items]
Weighted Average Remaining Contractual Life (years)	3 days
Minimum [Member] | 0.10 [Member]
Class of Warrant or Right [Line Items]
Weighted Average Remaining Contractual Life (years)	3 days
Minimum [Member] | 0.25 [Member]
Class of Warrant or Right [Line Items]
Weighted Average Remaining Contractual Life (years)	1 year 3 months
Minimum [Member] | 0.125 [Member]
Class of Warrant or Right [Line Items]
Weighted Average Remaining Contractual Life (years)	4 years 9 months 7 days
Minimum [Member] | 1.00 [Member]
Class of Warrant or Right [Line Items]
Weighted Average Remaining Contractual Life (years)	2 years 3 months
Maximum [Member] | 0.05 [Member]
Class of Warrant or Right [Line Items]
Weighted Average Remaining Contractual Life (years)	11 months 1 day
Maximum [Member] | 0.10 [Member]
Class of Warrant or Right [Line Items]
Weighted Average Remaining Contractual Life (years)	1 year 7 months 24 days
Maximum [Member] | 0.25 [Member]
Class of Warrant or Right [Line Items]
Weighted Average Remaining Contractual Life (years)	4 years 9 months
Maximum [Member] | 0.125 [Member]
Class of Warrant or Right [Line Items]
Weighted Average Remaining Contractual Life (years)	4 years 11 months 26 days
Maximum [Member] | 1.00 [Member]
Class of Warrant or Right [Line Items]
Weighted Average Remaining Contractual Life (years)	2 years 8 months 19 days

Convertible Promissory Notes (D

Convertible Promissory Notes (Details) - USD ($)	Jan. 25, 2021	Mar. 13, 2019	Nov. 19, 2020	Mar. 31, 2022	Apr. 18, 2022	Mar. 31, 2021	May 31, 2018	Apr. 02, 2018
Convertible Promissory Notes (Details) [Line Items]
Share issued (in Shares)				482	18,731,644
Conversion of common stock				$ 135,000
Accrued interest				49,734
Aggregate remaining amount				25,000
Aggregate remaining amount				1,200,000
Aggregate remaining amount short term				780,000
Aggregate remaining amount long term				$ 420,000
Convertible debt		$ 570,000
Maturity date				Nov. 19, 2021
Penalty Per day				$ 2,000
Derivative liabilities				$ 7,852,842
Common Stock [Member]
Convertible Promissory Notes (Details) [Line Items]
Share issued (in Shares)				12,461,909
Conversion of common stock				$ 69,900
Aggregate remaining amount						$ 37,500
Unsecured Convertible Promissory Note [Member]
Convertible Promissory Notes (Details) [Line Items]
Conversion price per share of debt, description				The Apr & May 2018 Notes had maturity dates of April 2, 2019 and May 31, 2019, respectively. The Apr & May 2018 Notes bear interest at 10% per year. The Apr & May 2018 Notes may be converted into shares of the Company’s common stock at a variable conversion price of 50% of the lesser of the lowest trading price twenty-five (25) trading days prior to conversion.
Aggregate remaining amount				$ 218,064			$ 300,000	$ 300,000
Investor amount		$ 570,000
Reserved shares (in Shares)		2,630,769
Unsecured Convertible Promissory Note [Member] | 2014-2015 Notes [Member]
Convertible Promissory Notes (Details) [Line Items]
Conversion price per share of debt, description				The 2014-2015 Notes bear interest at 10% per year. The maturity dates were extended to November 2023 through April 2024. The 2014-2015 Notes may be converted into shares of the Company’s common stock at conversion prices ranging from the lesser of $4,200 to $9,800 (subject to adjustment for stock splits, dividends, combinations and other similar transactions) or 50% of the lowest trade price on any trade day following issuance of the 2014-2015 Notes.
Aggregate remaining amount				$ 860,100
Unsecured Convertible Promissory Note [Member] | 2015-2016 Notes [Member]
Convertible Promissory Notes (Details) [Line Items]
Conversion price per share of debt, description				The 2015 Notes may be converted into shares of the Company’s common stock at conversion prices ranging from the lesser of $1,400 to $5,600 (subject to adjustment for stock splits, dividends, combinations and other similar transactions) or 50% of the lowest trade price on any trade day following issuance of the 2015 Notes.
Debt instrument interest rate				10.00%
Unsecured Convertible Promissory Note [Member] | Nov 20 Note [Member]
Convertible Promissory Notes (Details) [Line Items]
Aggregate remaining amount				$ 13,772
Convertible debt			$ 50,000
Convertible debt received funds			$ 50,000
Bears interest rate			10.00%
Unsecured convertible promissory note, description			The Nov 20 Note may be converted into shares of the Company’s common stock at a lesser price of $0.05 per share or (b) fifty percent (50%) of the lowest trade price of common stock recorded on any trade after the effective date, or (c) the lowest effective price per share granted. In addition, for each conversion, in event that shares are not delivered by the fourth business day (inclusive of the day of conversion), a penalty of $2,000 per day shall be assessed for each day after the third business day until the shares are delivered. The conversion feature of the Nov 20 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Note. As of March 31, 2022, the remaining balance on the Nov 20 Note was $13,772, which is long term.The Company entered into an unsecured convertible promissory note (the “Jan 21 Note”), on January 25, 2021 in the amount of $60,000. The Company received funds in the amount of $60,000. The Jan 21 Note matures on January 25, 2022, twelve months from the effective date of the Note. The Note may be extended sixty (60) months from the maturity date. The Jan 21 Note bears interest at 10% per year. The Jan 21 Note may be converted into shares of the Company’s common stock at a conversion price equal to the lower of (a) $0.05 per share, (b) fifty percent (50%) of the lowest trade price of common stock recorded on any trade after the effective date, or (c) the lowest effective price per share granted.
Unsecured Convertible Promissory Note [Member] | Jan 21 Note [Member]
Convertible Promissory Notes (Details) [Line Items]
Convertible debt	$ 60,000
Convertible debt received funds	$ 60,000
Unsecured convertible promissory note, description	The Note may be extended sixty (60) months from the maturity date. The Jan 21 Note bears interest at 10% per year. The Jan 21 Note may be converted into shares of the Company’s common stock at a conversion price equal to the lower of (a) $0.05 per share, (b) fifty percent (50%) of the lowest trade price of common stock recorded on any trade after the effective date, or (c) the lowest effective price per share granted.
Interest expense				3,743
Remaining debt amount				$ 60,000
Unsecured Convertible Promissory Note [Member] | Jan 21 Note [Member]
Convertible Promissory Notes (Details) [Line Items]
Maturity date	Jan. 25, 2022
Original Issue Discount [Member]
Convertible Promissory Notes (Details) [Line Items]
Conversion price per share of debt, description				After the amendment, the conversion price changed to the lesser of $5,600 per share, or b) fifty percent (50%) of the lowest trade price of common stock recorded since the original effective date of this note, or c) the lowest effective price per share granted to any person or entity after the effective date.
Aggregate remaining amount				$ 184,124
Accrued interest				13,334
Conversion into common stock				30,620
Long term promissory notes				62,275
Convertible Debt [Member] | Dec 2015 Note [Member]
Convertible Promissory Notes (Details) [Line Items]
Aggregate remaining amount				167,048
Accounts payable				$ 432,048
Percentage of average of lowest closing prices				75.00%
Convertible Debt [Member] | Sep 2016 Note [Member]
Convertible Promissory Notes (Details) [Line Items]
Aggregate remaining amount				$ 430,896
Accounts payable				$ 430,896
Percentage of average of lowest closing prices				75.00%

Convertible Promissory Notes _2

Convertible Promissory Notes (Details) - Schedule of outstanding convertible promissory notes	Mar. 31, 2022USD ($)
Schedule of outstanding convertible promissory notes [Abstract]
Convertible Promissory Notes	$ 3,012,155
Less current portion	1,596,008
Total long-term liabilities	$ 1,416,147

Convertible Promissory Notes _3

Convertible Promissory Notes (Details) - Schedule of maturities of long-term debt	Mar. 31, 2022USD ($)
Schedule of maturities of long-term debt [Abstract]
2023	$ 1,596,008
2024	1,312,275
2025	103,772
Total	$ 3,012,155

Revenue from Contracts with C_3

Revenue from Contracts with Customers (Details) - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Revenue from Contracts with Customers [Abstract]
Contract assets	$ 781,967	$ 378,932
Contract liability	$ 2,494,825	$ 1,886,946

Revenue from Contracts with C_4

Revenue from Contracts with Customers (Details) - Schedule of disaggregation of revenue by type of good or service from contracts with customers - Type of Good or Service [Member] - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Disaggregation of Revenue [Line Items]
Equipment Contracts	$ 812,245	$ 502,441
Component Sales	354,731	265,135
Waste Water Treatment Systems	49,460
Rental Income	6,573	8,114
Services Sales	11,096	20,488
Total	$ 1,234,105	$ 796,178

Financial Assets (Details)

Financial Assets (Details) - USD ($)	Nov. 12, 2021	May 15, 2018	Mar. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Interest and fees	$ 15,988
Aggregate amount	$ 149,867
Converted common stock (in Shares)	45,208,649
Investment in securities in fair value amount			$ 94,940
Unrealized gain			103,978
Fair value investment in securities description		the Company received 4,000 shares of WTII Series C convertible preferred stock for the use of OriginClear, Inc. technology associated with their proprietary electro water separation system. Each share of Series C convertible preferred stock is convertible into one thousand (1,000) shares of WTII common stock. The stock was valued at fair market value of $0.0075 for a price of $30,000 on the date of issuance. The Company analyzed the licensing agreement using ASU 606 to determine the timing of revenue recognition.
Preferred shares fair value			$ 8,800

Loans Payable (Details)

Loans Payable (Details) - USD ($)	Sep. 12, 2020	Apr. 30, 2020	Mar. 31, 2022	Dec. 31, 2021
Loans Payable (Details) [Line Items]
Company received settlement amount			$ 25,000
Accounts payable			50,000
Net balance			$ 30,646
Proceeds from loans received	$ 505,000	$ 505,000
Granted loan amount	10,000
Secured Loans Payable [Member]
Loans Payable (Details) [Line Items]
Leaving balance description			short term loans with various lenders for capital expansion secured by the Company’s assets in the amount of $1,749,970, which included finance cost of $624,810. The finance cost was amortized over the terms of the loans, which have various maturity dates ranging from October 2018 through February 2019. As of December 31, 2020, the finance cost was fully amortized. During the year ended December 31, 2021, the Company settled the majority of the loans in the amount of $262,250, of which $157,250 was recognized on the statement of operations as a gain on write-off of loan payable. The term of the loans ranged from two months to six months.
Paycheck Protection Program Loan [Member]
Loans Payable (Details) [Line Items]
Proceeds from loans received	$ 345,000
Economic Injury Disaster Loan [Member]
Loans Payable (Details) [Line Items]
Proceeds from loans received				$ 345,000
Granted loan amount		$ 150,000		$ 10,000

Capital Leases (Details)

Capital Leases (Details)	3 Months Ended
	Mar. 31, 2022USD ($)$ / shares
Capital Leases [Abstract]
Capital lease term	60 months
Monthly payments for lease	$ 757
Lease price (in Dollars per share) | $ / shares	$ 1
Capital leases current balance	$ 5,713

Assets Held For Sale (Details)

Assets Held For Sale (Details)	3 Months Ended
	Mar. 31, 2022USD ($)
Property, Plant and Equipment Assets Held-for-sale Disclosure [Abstract]
Preferred stock fair value	$ 630,000
Fair value adjusted	116,000
Leaving a fair value	$ 514,000

Commitments and Contingencies (

Commitments and Contingencies (Details)	1 Months Ended
	Jan. 24, 2022USD ($)	Mar. 31, 2022USD ($)m²	Mar. 13, 2019USD ($)
Commitments and Contingencies (Details) [Line Items]
Monthly rent		$ 7,900
Warrant reserve		$ 20,000
Defendants paid	$ 25,000
Convertible notes			$ 570,000
Mckinney [Member]
Commitments and Contingencies (Details) [Line Items]
Area of land (in Square Meters) | m²		0

Subsequent Events (Details)

Subsequent Events (Details) - USD ($)	May 11, 2022	Apr. 19, 2022	Apr. 10, 2022	Apr. 06, 2022	Apr. 28, 2022	Apr. 26, 2022	Apr. 25, 2022	Apr. 18, 2022	Mar. 31, 2022	May 10, 2022
Subsequent Events (Details) [Line Items]
Aggregate converted shares	512,737
Aggregate shares issued								18,731,644	482
Subsequent Event [Member]
Subsequent Events (Details) [Line Items]
Aggregate of shares				5,000,000						5,000,000
Aggregate converted shares								4,565,014
Series Y Preferred Stock [Member] | Subsequent Event [Member]
Subsequent Events (Details) [Line Items]
Aggregate shares of common stock				6.25			4,230,769
Aggregate purchase price (in Dollars)					$ 625,000
Aggregate converted shares							50
Series K Preferred Stock [Member] | Subsequent Event [Member]
Subsequent Events (Details) [Line Items]
Aggregate converted shares								50
Series W Preferred Stock [Member] | Subsequent Event [Member]
Subsequent Events (Details) [Line Items]
Aggregate shares of common stock		3,117,364						50
Aggregate of shares		518,232
Aggregate converted shares		35	10
Series T Preferred Stock [Member]
Subsequent Events (Details) [Line Items]
Aggregate of shares									145
Series T Preferred Stock [Member] | Subsequent Event [Member]
Subsequent Events (Details) [Line Items]
Aggregate shares of common stock							9,230,770
Aggregate converted shares							60
Series L Preferred Stock [Member]
Subsequent Events (Details) [Line Items]
Aggregate shares of common stock									14,528,106
Aggregate converted shares									124
Series L Preferred Stock [Member] | Subsequent Event [Member]
Subsequent Events (Details) [Line Items]
Aggregate shares of common stock						1,445,086
Aggregate converted shares						10
Series R Preferred Stock [Member]
Subsequent Events (Details) [Line Items]
Aggregate of shares									378
Series R Preferred Stock [Member] | Subsequent Event [Member]
Subsequent Events (Details) [Line Items]
Aggregate shares of common stock						2,504,816
Aggregate converted shares						20
Series I Preferred Stock [Member] | Subsequent Event [Member]
Subsequent Events (Details) [Line Items]
Aggregate converted shares			10
Series J Preferred Stock [Member] | Subsequent Event [Member]
Subsequent Events (Details) [Line Items]
Aggregate converted shares	5